cbm20170930_10q.htm

0001437749-17-018451.txt : 20171107 0001437749-17-018451.hdr.sgml : 20171107 20171107070146 ACCESSION NUMBER: 0001437749-17-018451 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 59 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171107 DATE AS OF CHANGE: 20171107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CAMBREX CORP CENTRAL INDEX KEY: 0000820081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222476135 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-10638 FILM NUMBER: 171181069 BUSINESS ADDRESS: STREET 1: ONE MEADOWLANDS PLZ CITY: E RUTHERFORD STATE: NJ ZIP: 07073 BUSINESS PHONE: 2018043000 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: E. RUTHERFORD STATE: NJ ZIP: 07073 10-Q 1 cbm20170930_10q.htm FORM 10-Q cbm20170930_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE

SECURITIES EXCHANGE ACT OF 1934

for the quarterly period ended September 30, 2017

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

for the transition period from to

Commission file number 1-10638

CAMBREX CORPORATION

(Exact name of registrant as specified in its charter)

DELAWARE	22-2476135
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

ONE MEADOWLANDS PLAZA, EAST RUTHERFORD, NEW JERSEY 07073

(Address of principal executive offices)

(201) 804-3000

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ (Do not check if a smaller reporting company) Smaller reporting company ☐ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 2, 2017, there were 32,777,576 shares outstanding of the registrant’s Common Stock, $.10 par value.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Table of Contents

			Page No.
Part I	Financial Information		3

	Item 1.	Financial Statements	3

		Consolidated Balance Sheets	3

		Consolidated Income Statements	4

		Consolidated Statements of Comprehensive Income	5

		Consolidated Statements of Cash Flows	6

		Notes to Consolidated Financial Statements	7

	Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	24

	Item 3.	Quantitative and Qualitative Disclosures about Market Risk	31

	Item 4.	Controls and Procedures	31

Part II	Other Information		32

	Item 1.	Legal Proceedings	32

	Item 1A.	Risk Factors	32

	Item 6.	Exhibits	32

Signatures			33

Table of Contents

Forward-Looking Statements

This document contains and incorporates by reference forward-looking statements including statements regarding expected performance, including, but not limited to, the Company’s belief that cash flows from operations, along with funds available from the revolving line of credit, will be adequate to meet the operational and debt servicing needs of the Company, as well as other statements relating to expectations with respect to sales, the timing of orders, research and development expenditures, earnings per share, capital expenditures, the outcome of pending litigation (including environmental proceedings and remediation investigations) and related estimates of potential liability, acquisitions, divestitures, collaborations or other expansion opportunities. These statements may be identified by the fact that they use words such as “may,” “will,” “could,” “should,” “would,” “expect,” “anticipate,” “intend,” “estimate,” “believe” or similar expressions. Any forward-looking statements contained herein are based on current plans and expectations and involve risks and uncertainties that could cause actual outcomes and results to differ materially from current expectations. The factors described in Item 1A of Part I contained in the Company’s Annual Report on Form 10-K for the period ended December 31, 2016, captioned “Risk Factors,” or otherwise described in the Company’s filings with the Securities and Exchange Commission, provide examples of such risks and uncertainties that may cause the Company’s actual results to differ materially from the expectations the Company describes in its forward-looking statements, including, but not limited to, pharmaceutical outsourcing trends, competitive pricing or product developments, government legislation and regulations (particularly environmental issues), tax rates, interest rates, technology, manufacturing and legal issues, including the outcome of outstanding litigation, changes in foreign exchange rates, uncollectible receivables, the timing of orders, loss on disposition of assets, cancellation or delays in renewal of contracts, lack of suitable raw materials or packaging materials, the Company’s ability to receive regulatory approvals for its products and continued demand in the U.S. for late stage clinical products or the successful outcome of the Company’s investment in new products.

The forward-looking statements are based on the beliefs and assumptions of Company management and the information available to Company management as of the date of this report. The Company cautions investors not to place significant reliance on expectations regarding future results, levels of activity, performance, achievements or other forward-looking statements. The information contained in this Quarterly Report on Form 10-Q is provided by the Company as of the date hereof, and, unless required by law, the Company does not undertake and specifically disclaims any obligation to update these forward-looking statements contained in this Quarterly Report on Form 10-Q as a result of new information, future events or otherwise.

Table of Contents

Part I - FINANCIAL INFORMATION

Item 1. Financial Statements

CAMBREX CORPORATION AND SUBSIDIARIES

Consolidated Balance Sheets

(in thousands, except share data)

	September 30,			December 31,
	2017			2016
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	118,403		$	74,141
Trade receivables, net		81,776			110,622
Other receivables		7,901			6,748
Inventories, net		164,913			123,184
Prepaid expenses and other current assets		5,089			7,960
Total current assets		378,082			322,655

Property, plant and equipment, net		248,945			217,092
Goodwill		43,200			40,323
Intangible assets, net		14,229			14,800
Deferred income taxes		10,512			13,061
Other non-current assets		3,383			3,934

Total assets	$	698,351		$	611,865

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	39,874		$	42,873
Deferred revenue and advance payments		8,024			7,506
Taxes payable		463			9,469
Accrued expenses and other current liabilities		35,856			35,614
Total current liabilities		84,217			95,462

Advance payments		39,000			39,000
Deferred income taxes		9,103			6,921
Accrued pension benefits		44,267			43,109
Other non-current liabilities		23,887			21,946
Total liabilities		200,474			206,438

Stockholders' equity:
Common stock, $.10 par value; authorized 100,000,000, issued 34,207,225 and 33,927,595 shares at respective dates		3,421			3,393
Additional paid-in capital		162,140			153,681
Retained earnings		389,567			327,376
Treasury stock, at cost, 1,433,649 and 1,583,909 shares at respective dates		(12,221	)		(13,503	)
Accumulated other comprehensive loss		(45,030	)		(65,520	)

Total stockholders' equity		497,877			405,427

Total liabilities and stockholders' equity	$	698,351		$	611,865

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Consolidated Income Statements

(unaudited – in thousands, except per share data)

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016

Gross sales	$	112,233		$	99,867		$	350,431		$	312,856
Commissions, allowances and rebates		225			565			1,468			1,901

Net sales		112,008			99,302			348,963			310,955

Other revenues, net		611			97			3,216			1,823

Net revenue		112,619			99,399			352,179			312,778

Cost of goods sold		65,730			61,797			200,963			187,720

Gross profit		46,889			37,602			151,216			125,058

Operating expenses:
Selling, general and administrative expenses		17,551			14,950			51,785			42,602
Research and development expenses		4,233			3,193			12,590			10,796
Total operating expenses		21,784			18,143			64,375			53,398

Operating profit		25,105			19,459			86,841			71,660

Other expenses/(income):
Interest expense, net		337			366			991			357
Other (income)/expenses, net		(6	)		(71	)		(149	)		143
Income before income taxes		24,774			19,164			85,999			71,160

Provision for income taxes		7,498			5,443			22,484			21,784

Income from continuing operations		17,276			13,721			63,515			49,376

Income/(loss) from discontinued operations, net of tax		20			(4,503	)		(1,324	)		(5,082	)

Net income	$	17,296		$	9,218		$	62,191		$	44,294

Basic earnings/(loss) per share of common stock:
Income from continuing operations	$	0.53		$	0.43		$	1.95		$	1.54
Income/(loss) from discontinued operations, net of tax	$	0.00		$	(0.14	)	$	(0.04	)	$	(0.16	)
Net income	$	0.53		$	0.29		$	1.91		$	1.38

Diluted earnings/(loss) per share of common stock:
Income from continuing operations	$	0.52		$	0.42		$	1.90		$	1.50
Income/(loss) from discontinued operations, net of tax	$	0.00		$	(0.14	)	$	(0.04	)	$	(0.15	)
Net income	$	0.52		$	0.28		$	1.86		$	1.35

Weighted average shares outstanding:
Basic		32,749			32,149			32,612			32,034
Effect of dilutive stock based compensation		763			850			839			871
Diluted		33,512			32,999			33,451			32,905

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Consolidated Statements of Comprehensive Income

(unaudited – in thousands)

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016

Net income	$	17,296	$	9,218	$	62,191	$	44,294

Other comprehensive income:

Foreign currency translation adjustments		7,006		235		19,753		947

Pension plan amortization of net actuarial loss and prior service cost, net of tax of $118, $100, $350 and $300 at respective dates		250		202		737		606

Comprehensive income	$	24,552	$	9,655	$	82,681	$	45,847

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(unaudited – in thousands)

	Nine months ended
	September 30,
	2017		2016
Cash flows from operating activities:
Net income	$	62,191	$	44,294
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		23,023		17,717
Non-cash deferred revenue		(4,991)		(2,972)
Increase in inventory reserve		3,217		5,950
Stock based compensation		6,321		5,189
Deferred income tax provision		1,087		7,838
Other		516		265
Changes in assets and liabilities:
Trade receivables		35,995		44,213
Inventories		(38,245)		(40,088)
Prepaid expenses and other current assets		(70)		(2,144)
Accounts payable and other current liabilities		(16,422)		(8,504)
Deferred revenue and advance payments		512		39,363
Other non-current assets and liabilities		(2,282)		(2,764)
Discontinued operations:
Non-current liabilities		2,418		6,748
Net cash used in discontinued operations		(1,185)		(312)
Net cash provided by operating activities		72,085		114,793

Cash flows from investing activities:
Capital expenditures		(38,241)		(37,706)
Proceeds from sale of business		2,836		-
Other		-		13
Net cash used in investing activities		(35,405)		(37,693)

Cash flows from financing activities:
Repayment of debt		-		(30,000)
Proceeds from stock options exercised		3,448		2,116
Debt issuance costs		-		(2,515)
Net cash provided by/(used in) financing activities		3,448		(30,399)

Effect of exchange rate changes on cash and cash equivalents		4,134		61

Net increase in cash and cash equivalents		44,262		46,762

Cash and cash equivalents at beginning of period		74,141		43,974

Cash and cash equivalents at end of period	$	118,403	$	90,736

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(1)

Basis of Presentation

Unless otherwise indicated by the context, "Cambrex" or the "Company" means Cambrex Corporation and subsidiaries.

The accompanying unaudited consolidated financial statements have been prepared from the records of the Company. In the opinion of management, the financial statements include all adjustments, which are of a normal and recurring nature, except as otherwise described herein, and are necessary for a fair statement of financial position and results of operations in conformity with U.S. generally accepted accounting principles (“GAAP”). These interim financial statements should be read in conjunction with the financial statements for the year ended December 31, 2016.

The results of operations of any interim period are not necessarily indicative of the results expected for the full year.

For all periods presented, financial results for discontinued operations relate to environmental investigation and remediation at sites of divested businesses.

Certain reclassifications have been made to prior year amounts to conform with current year presentation.

(2)	Impact of Recently Issued Accounting Pronouncements

The following accounting pronouncements became effective for the Company in the first nine months of 2017:

Simplification of Employee Share-Based Payment Accounting

In March 2016, the FASB issued ASU 2016-09 which simplifies several aspects of the accounting for employee share-based payment transactions, including the accounting for income taxes, forfeitures and classification in the statement of cash flows. This standard became effective for the Company on January 1, 2017. The new standard requires recognition of excess tax benefits that had not previously been recognized. The Company had no remaining unrecognized excess tax benefits as of December 31, 2016. All excess tax benefits and deficiencies in future periods will be recorded as part of the current period tax provision within the Income Statement. This will result in increased volatility in the Company’s effective tax rate. During the first nine months of 2017, the Company recognized a tax benefit of $5,114 which lowered the effective tax rate by 6.0%. No other provisions in this new standard had a significant impact on the consolidated financial statements including the Company’s accounting policy election to account for forfeitures when they occur.

To conform to the current year presentation, the Company reclassified $2,958 of excess tax benefits under financing activities to operating activities for the nine months ended September 30, 2016 on the consolidated statement of cash flows.

Simplifying the Measurement of Inventory

In July 2015, the FASB issued ASU 2015-11 which requires that inventory be measured at the lower of cost and net realizable value, and eliminates the other two options that currently exist for market, replacement cost and net realizable value less an approximately normal profit margin. This update became effective on January 1, 2017 and did not have a material impact on the Company’s consolidated financial statements.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(2)

Impact of Recently Issued Accounting Pronouncements (continued)

The following recently issued accounting pronouncements will become effective for the Company in the future:

Business Combinations – Clarifying the Definition of a Business

In January 2017, the FASB issued ASU 2017-01 which clarifies the definition of a business to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The standard introduces a screen for determining when assets acquired are not a business and clarifies that a business must include, at a minimum, an input and a substantive process that contribute to an output to be considered a business. This standard is effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period. The Company does not expect this new guidance to have a material impact on its consolidated financial statements.

Statement of Cash Flows – Restricted Cash

In November 2016, the FASB issued ASU 2016-18 which clarifies the presentation requirements of restricted cash within the statement of cash flows. The changes in restricted cash and restricted cash equivalents during the period should be included in the beginning and ending cash and cash equivalents balance reconciliation on the statement of cash flows. When cash, cash equivalents, restricted cash or restricted cash equivalents are presented in more than one line item within the statement of financial position, an entity shall calculate a total cash amount in a narrative or tabular format that agrees to the amount shown on the statement of cash flows. Details on the nature and amounts of restricted cash should also be disclosed. This standard is effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period. The Company does not expect this new guidance to have a material impact on its consolidated financial statements.

Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments

In August 2016, the FASB issued ASU 2016-15 which provides guidance on the presentation and classification in the statement of cash flows for specific cash receipt and payment transactions, including debt prepayment or extinguishment costs, contingent consideration payments made after a business combination, proceeds from the settlement of insurance claims and corporate-owned life insurance policies, and distributions received from equity method investees. This standard is effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period. The Company does not expect this new guidance to have a material impact on its consolidated financial statements.

Leases

In February 2016, the FASB issued ASU 2016-02 which requires lessees to recognize right of use assets and lease liabilities on the balance sheet for all leases except short-term leases. On the income statement, leases will be classified as operating or finance leases. This standard is effective for fiscal years beginning after December 15, 2018, including interim periods within that reporting period. At this time, the Company has no financing leases and only a limited number of operating leases. The result of adoption will be an increase to assets and liabilities by the same amount for the identified operating leases. This adjustment will not be material to the Company, assuming there is not an increase in lease activity.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(2)

Impact of Recently Issued Accounting Pronouncements (continued)

Revenue from Contracts with Customers

In May 2014, the FASB issued ASU 2014-09 that introduces a new five-step revenue recognition model in which an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires disclosures sufficient to enable users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers, including qualitative and quantitative disclosures about contracts with customers, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. Numerous updates were issued in 2016 that provide clarification on a number of specific issues as well as requiring additional disclosures. The new standard is effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period. On January 1, 2018, the Company will adopt the new accounting standard for all contracts not completed as of the adoption date using the modified retrospective method. Certain sales that would have otherwise been reflected in the income statement in 2018 will now be recorded in equity as part of a cumulative effect adjustment. Additionally, a portion of certain products that will be in process at December 31, 2018 will be eligible for revenue recognition in 2018 as opposed to when they would ship in 2019 under previous guidance.

The Company continues to evaluate the impact of adoption of the new standard on revenue recognition policies, internal controls, reporting and disclosures. As part of this evaluation, the Company has identified the revenue streams and reviewed the related critical customer contract terms and provisions. The Company has concluded that the timing of the recognition of revenue for products to specific customers with no alternative use, that were previously recognized upon delivery, will be recognized over time utilizing a measure of progress toward satisfaction of the performance obligations. Generally, under these customer agreements, the Company is entitled to compensation for progress to date that includes an element of profit margin. Depending on the amount of these projects in process at the end of 2017, the cumulative adjustment could be significant, but at this time cannot be reasonably estimated. These products represented nearly half of 2016 net revenue. The Company will also record contract balances on the balance sheet and present all related disclosures in the notes to financial statements. The Company continues to assess the impact of the related disclosures as well as finalizing a methodology and process for recognizing product revenue over time.

Presentation of Net Periodic Benefit Cost Related to Defined Benefit Plans

In March 2017, the FASB issued ASU 2017-07 which amends the requirements in ASC 715 related to the income statement presentation of the components of net periodic benefit cost for an entity’s sponsored defined pension and other postretirement plans. The ASU requires entities to (1) disaggregate the current-service-cost component from the other components of net benefit cost and present it with other current compensation costs for related employees in the income statement and (2) present the other components elsewhere in the income statement and outside of income from operations if such subtotal is presented. The ASU also requires entities to disclose the income statement lines that contain the other components if they are not presented separately. The ASU’s amendment is effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period. The Company does not expect this new guidance to have an impact on its consolidated financial statements.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(2)

Impact of Recently Issued Accounting Pronouncements (continued)

Simplifying the Test for Goodwill Impairment

In January 2017, the FASB issued ASU 2017-04 which simplifies the goodwill impairment test by eliminating Step 2 in the determination on whether goodwill should be considered impaired. Instead, an impairment charge should equal the amount by which a reporting unit’s carrying amount exceeds its fair value, not to exceed the amount of goodwill allocated to the reporting unit. The new standard is effective for fiscal years beginning after December 15, 2019, including interim periods within that reporting period. The Company is currently evaluating the new guidance and does not expect it to have an impact on its consolidated financial statements.

Scope of Modification Accounting, Stock Based Compensation

In May 2017, the FASB issued ASU 2017-09 which provides clarification on when modification accounting should be used for changes to the terms or conditions of a share-based payment award. This ASU does not change the accounting for modifications but clarifies that modification accounting guidance should only be applied if there is a change to the value, vesting conditions, or award classification and would not be required if the changes are considered non-substantive. The amendment is effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements.

Targeted Improvements to Accounting for Hedging Activities

In August 2017, the FASB issued ASU 2017-12 which improves the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. The standard also makes certain targeted improvements to simplify the application of the hedge accounting guidance. The amendment is effective for fiscal years beginning after December 15, 2018, including interim periods within that reporting period. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements.

(3)	Net Inventories

Inventories are stated at the lower of cost and net realizable value. Cost is determined on a first-in, first-out basis.

Net inventories consist of the following:

	September 30,		December 31,
	2017		2016

Finished goods	$	49,771	$	29,117
Work in process		64,168		54,463
Raw materials		44,355		33,841
Supplies		6,619		5,763
Total	$	164,913	$	123,184

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(4)	Goodwill and Intangible Assets

The change in the carrying amount of goodwill for the nine months ended September 30, 2017, is as follows:

Balance as of December 31, 2016	$	40,323
Translation effect		2,877
Balance as of September 30, 2017	$	43,200

Acquired intangible assets, which are amortized, consist of the following:

				As of September 30, 2017
	Amortization Period (in years)			Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount

Internal-use software	3	-	7	$	6,971	$	(1,535	)	$	5,436
Technology-based intangibles		20			3,589		(1,346	)		2,243
Customer-related intangibles	10	-	15		7,597		(1,047	)		6,550
				$	18,157	$	(3,928	)	$	14,229

				As of December 31, 2016
	Amortization Period (in years)			Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount

Internal-use software	3	-	7	$	6,444	$	(829	)	$	5,615
Technology-based intangibles		20			3,204		(1,082	)		2,122
Customer-related intangibles	10	-	15		7,522		(459	)		7,063
				$	17,170	$	(2,370	)	$	14,800

The change in the gross carrying amount is due to additions and the impact of foreign currency translation.

Amortization expense was $477 and $1,375 for the three and nine months ended September 30, 2017, respectively. Amortization expense was $227 and $614 for the three and nine months ended September 30, 2016, respectively.

Amortization expense related to intangible assets is expected to be approximately $1,881 for 2017, $2,019 for 2018 and 2019, and $2,003 for 2020 and 2021.

(5)	Income Taxes

Income tax expense from continuing operations for the three and nine months ended September 30, 2017 was $7,498 and $22,484, respectively, compared to $5,443 and $21,784 for the three and nine months ended September 30, 2016, respectively. The effective tax rate for the three and nine months ended September 30, 2017 was 30.3% and 26.1%, respectively, compared to 28.4% and 30.6% for the three and nine months ended September 30, 2016, respectively. Tax expense for the nine months ended September 30, 2017 was favorably impacted by $5,114 as a result of applying ASU 2016-09. The standard requires recognition immediately in the tax provision of certain effects of share-based payments that were possibly deferred under the previous guidance. Excluding the effects of applying the new standard, the effective tax rate for the nine months ended September 30, 2017 was 32.1%.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(6)	Derivatives

The Company operates internationally and is exposed to fluctuations in foreign exchange rates and interest rates in the normal course of business. The Company, from time to time, uses derivatives to reduce exposure to market risks resulting from fluctuations in interest rates and foreign exchange rates.

All financial instruments involve market and credit risks. The Company is exposed to credit losses in the event of non-performance by the counterparties to the contracts. While there can be no assurance, the Company does not anticipate non-performance by these counterparties.

Foreign Currency Forward Contracts

The Company periodically enters into foreign currency forward contracts to protect against currency fluctuations of forecasted cash flows and existing balance sheet exposures at its foreign operations, as deemed appropriate. The Company may or may not elect to designate certain forward contracts for hedge accounting treatment.

For derivatives that are not designated for hedge accounting treatment, changes in the fair value are immediately recognized in earnings. This treatment has the potential to increase volatility of the Company’s earnings.

None of the foreign currency forward contracts entered into during the nine months ended September 30, 2017 and 2016 were designated for hedge accounting treatment. The notional amounts of the Company’s outstanding foreign exchange forward contracts were $37,626 and $20,896 at September 30, 2017 and December 31, 2016, respectively. The Company does not hold or purchase any foreign currency forward contracts for trading or speculative purposes and no contractual term is greater than twelve months.

The fair value of the Company’s foreign exchange forward contracts outstanding was a gain of $193 and $125 at September 30, 2017 and December 31, 2016, respectively. Losses are recorded in “Accrued expenses and other current liabilities” and gains are recorded in “Prepaid expenses and other current assets” on the balance sheet and “Other revenues, net” on the income statement.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(7)	Fair Value Measurements

U.S. GAAP establishes a valuation hierarchy for disclosure of the inputs to the valuations used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows: Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation; Level 3 inputs are unobservable inputs based on the Company’s assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

The following table provides the assets and liabilities carried at fair value, measured on a recurring basis, as of September 30, 2017 and December 31, 2016:

Fair Value - Level 2		September 30, 2017				December 31, 2016
Foreign currency forwards, assets		$	193			$	125

The Company’s foreign currency forward contracts are measured at fair value using observable market inputs such as forward rates, the Company’s credit risk and its counterparties’ credit risks. Based on the Company’s continued ability to enter into forward contracts, the Company considers the markets for its fair value instruments to be active.

The Company’s financial instruments also include cash and cash equivalents, accounts receivables and accounts payables. The carrying amount of these instruments approximates fair value because of their short-term nature.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(8)	Accumulated Other Comprehensive Income/(Loss)

The following tables provide the changes in AOCI by component (pension, net of tax) for the three months ended September 30, 2017 and 2016:

	Foreign Currency Translation Adjustments			Pension Plans			Total
Balance as of June 30, 2017	$	(21,543	)	$	(30,743	)	$	(52,286	)
Other comprehensive income before reclassifications		7,006			-			7,006
Amounts reclassified from accumulated other comprehensive loss		-			250			250
Net current-period other comprehensive income		7,006			250			7,256
Balance as of September 30, 2017	$	(14,537	)	$	(30,493	)	$	(45,030	)

	Foreign Currency Translation Adjustments			Pension Plans			Total
Balance as of June 30, 2016	$	(25,168	)	$	(29,165	)	$	(54,333	)
Other comprehensive income before reclassifications		235			-			235
Amounts reclassified from accumulated other comprehensive loss		-			202			202
Net current-period other comprehensive income		235			202			437
Balance as of September 30, 2016	$	(24,933	)	$	(28,963	)	$	(53,896	)

The following tables provide the changes in AOCI by component (pension, net of tax) for the nine months ended September 30, 2017 and 2016:

	Foreign Currency Translation Adjustments			Pension Plans			Total
Balance as of December 31, 2016	$	(34,290	)	$	(31,230	)	$	(65,520	)
Other comprehensive income before reclassifications		19,753			-			19,753
Amounts reclassified from accumulated other comprehensive loss		-			737			737
Net current-period other comprehensive income		19,753			737			20,490
Balance as of September 30, 2017	$	(14,537	)	$	(30,493	)	$	(45,030	)

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(8)	Accumulated Other Comprehensive Income/(Loss) (continued)

	Foreign Currency Translation Adjustments			Pension Plans			Total
Balance as of December 31, 2015	$	(25,880	)	$	(29,569	)	$	(55,449	)
Other comprehensive income before reclassifications		947			-			947
Amounts reclassified from accumulated other comprehensive loss		-			606			606
Net current-period other comprehensive income		947			606			1,553
Balance as of September 30, 2016	$	(24,933	)	$	(28,963	)	$	(53,896	)

The following tables provide the reclassifications from AOCI by component for the three and nine months ended September 30, 2017 and 2016:

Details about AOCI Components	Three months ended September 30, 2017			Nine months ended September 30, 2017

Amortization of defined benefit pension items:
Actuarial losses	$	(355	)	$	(1,048	)
Prior service costs		(13	)		(39	)
Total before tax		(368	)		(1,087	)
Tax benefit		118			350
Net of tax	$	(250	)	$	(737	)

Total reclassification for the period	$	(250	)	$	(737	)

Details about AOCI Components	Three months ended September 30, 2016			Nine months ended September 30, 2016

Amortization of defined benefit pension items:
Actuarial losses	$	(288	)	$	(867	)
Prior service costs		(14	)		(39	)
Total before tax		(302	)		(906	)
Tax benefit		100			300
Net of tax	$	(202	)	$	(606	)

Total reclassification for the period	$	(202	)	$	(606	)

The Company recognizes net periodic benefit cost, which includes amortization of actuarial losses and gains, and prior service costs in both “Selling, general and administrative expenses” and “Cost of goods sold” in its income statement depending on the functional area of the underlying employees included in the plan.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(9)	Stock Based Compensation

The Company recognizes compensation costs for stock options awarded to employees based on their grant-date fair value. The value of each stock option is estimated on the date of grant using the Black-Scholes option-pricing model. The weighted-average fair value per share for the stock options granted to employees during the nine months ended September 30, 2017 was $20.14. The weighted-average fair value per share for the stock options granted to employees during the nine months ended September 30, 2016 was $13.82.

For the three months ended September 30, 2017 and 2016, the Company recorded $1,187 and $1,012, respectively, in “Selling, general and administrative expenses” for stock options. For the nine months ended September 30, 2017 and 2016, the Company recorded $3,313 and $2,836, respectively, in “Selling, general and administrative expenses” for stock options. As of September 30, 2017, the total compensation cost related to unvested stock options not yet recognized was $7,224. The cost will be amortized on a straight-line basis over the remaining weighted-average vesting period of 1.9 years.

The following table is a summary of the Company’s stock options:

Options	Number of Shares			Weighted Average Exercise Price

Outstanding at December 31, 2016		1,519,338		$	25.22
Granted		39,037			54.15
Exercised		(61,249	)		11.83
Outstanding at March 31, 2017		1,497,126			26.52
Granted		19,598			58.98
Exercised		(162,431	)		13.84
Outstanding at June 30, 2017		1,354,293			28.51
Exercised		(55,950	)		8.48
Outstanding at September 30, 2017		1,298,343			29.37
Exercisable at September 30, 2017		449,959		$	21.09

The aggregate intrinsic values for all stock options exercised for the three and nine months ended September 30, 2017 were $2,669 and $12,011, respectively. The aggregate intrinsic values for all stock options exercised for the three and nine months ended September 30, 2016 were $173 and $8,195, respectively. The aggregate intrinsic values for all stock options outstanding and exercisable as of September 30, 2017 were $33,350 and $15,256, respectively.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(9)	Stock Based Compensation (continued)

The following table is a summary of the Company’s unvested stock options, restricted stock and performance shares for which the requisite service period has not been rendered but that are expected to vest on the achievement of a performance condition:

	Unvested Stock Options					Unvested Restricted Stock					Unvested Performance Shares
	Number of Shares			Weighted- Average Grant-Date Fair Value		Number of Shares			Weighted- Average Grant-Date Fair Value		Number of Shares			Weighted- Average Grant-Date Fair Value

Unvested at December 31, 2016		817,540		$	12.50		260		$	41.05		316,750		$	30.08
Granted		39,037			21.02		-			-		-			-
Vested during period		(14,975	)		8.16		-			-		-			-
Unvested at March 31, 2017		841,602			12.97		260			41.05		316,750			30.08
Granted		19,598			18.37		9,496			58.98		5,750			41.36
Vested during period		(12,816	)		8.50		(260	)		41.05		-			-
Unvested at June 30, 2017		848,384			13.17		9,496			58.98		322,500			30.28
Vested during period		-			-		-			-		(150,000	)		17.81
Unvested at September 30, 2017		848,384		$	13.17		9,496		$	58.98		172,500		$	41.12

For the three months ended September 30, 2017 and 2016, the Company recorded $280 and $240, respectively, in “Selling, general and administrative expenses” for restricted stock awards. For the nine months ended September 30, 2017 and 2016, the Company recorded $474 and $406, respectively, in “Selling, general and administrative expenses” for restricted stock awards. As of September 30, 2017, total compensation cost related to unvested restricted stock not yet recognized was $93. The cost will be amortized on a straight-line basis over the remaining weighted-average vesting period of 0.1 years.

The Company granted equity-settled performance shares (“PS”) to certain executives. PS awards provide the recipient the right to receive a certain number of shares of the Company’s common stock in the future, which depends on the Company’s level of achievement of net revenue and EBITDA growth as compared to the net revenue and EBITDA growth of the members of a specified peer group of companies over a three year period. For the three months ended September 30, 2017 and 2016, the Company recorded $821 and $637, respectively, in “Selling, general and administrative expenses” related to these PS awards. For the nine months ended September 30, 2017 and 2016, the Company recorded $2,534 and $1,947, respectively, in “Selling, general and administrative expenses” related to these PS awards. As of September 30, 2017, total compensation cost related to unvested performance shares not yet recognized was $3,143. The cost will be amortized on a straight-line basis over the remaining weighted-average vesting period of 1.3 years.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(10)

Retirement Plans

Domestic Pension Plan

The components of net periodic benefit cost for the Company’s domestic pension plan (which was frozen in 2007) for the three and nine months ended September 30, 2017 and 2016 were as follows:

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016

Components of net periodic benefit cost
Interest cost	$	553		$	597		$	1,661		$	1,792
Expected return on plan assets		(677	)		(662	)		(2,031	)		(1,986	)
Recognized actuarial loss		199			194			599			582
Net periodic benefit cost	$	75		$	129		$	229		$	388

The Company’s Supplemental Executive Retirement Plan (which was frozen in 2007) is non-qualified and unfunded. Net periodic benefit cost for the three months ended September 30, 2017 and 2016 were $77 and $65, respectively. Net periodic benefit cost for the nine months ended September 30, 2017 and 2016 were $231 and $194, respectively.

International Pension Plan

The components of net periodic benefit cost for the Company’s international pension plan for the three and nine months ended September 30, 2017 and 2016 were as follows:

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016

Components of net periodic benefit cost
Service cost	$	247		$	186		$	700		$	561
Interest cost		192			186			545			560
Recognized actuarial loss		94			49			268			147
Amortization of prior service benefit		(1	)		(1	)		(3	)		(3	)
Net periodic benefit cost	$	532		$	420		$	1,510		$	1,265

(11)	Contingencies

The Company is subject to various investigations, claims and legal proceedings covering a wide range of matters that arise in the ordinary course of its business activities. The Company continually assesses known facts and circumstances as they pertain to applicable legal and environmental matters and evaluates the need for reserves and disclosures as deemed necessary based on these facts and circumstances. These matters, either individually or in the aggregate, could result in actual costs that are significantly higher than the Company’s current assessment and could have a material adverse effect on the Company's operating results and cash flows in future reporting periods. Based upon past experience, the Company believes that payments significantly in excess of current reserves, if required, would be made over an extended number of years.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(11)	Contingencies (continued)

Environmental

In connection with laws and regulations pertaining to the protection of the environment, the Company and its subsidiaries are a party to several environmental proceedings and remediation activities and along with other companies, have been named a potentially responsible party (“PRP”) for certain waste disposal sites ("Superfund sites"). All of the liabilities currently recorded on the Company’s balance sheet for environmental proceedings are associated with discontinued operations. The Company had insurance policies in place at certain of the discontinued operations for certain years that the Company believes should cover some portion of the recorded liabilities or potential future liabilities and the Company expects the net cash impact related to the contingencies described below to be reduced by the applicable income tax rate.

It is the Company’s policy to record appropriate liabilities for environmental matters where remedial efforts are probable and the costs can be reasonably estimated. Such liabilities are based on the Company’s estimate of the undiscounted future costs required to complete the remedial work. Each of these matters is subject to various uncertainties, and it is possible that some of these matters will be decided against the Company. The resolution of such matters often spans several years and frequently involves regulatory oversight or adjudication. Additionally, many remediation requirements are fluid and are likely to be affected by future technological, site and regulatory developments. It is not possible at this time for the Company to determine fully the effect of all asserted and unasserted claims on its consolidated financial condition, results of operations or liquidity; however, to the extent possible, where asserted and unasserted claims can be estimated and where such claims are considered probable, the Company would record a liability. Consequently, the ultimate liability with respect to such matters, as well as the timing of cash disbursements, is uncertain.

In matters where the Company is able to reasonably estimate the probable and estimable costs associated with environmental proceedings, the Company accrues for the estimated costs associated with the study and remediation of applicable sites. At September 30, 2017, the reserves were $17,434, of which $16,881 is included in “Other non-current liabilities” on the Company’s balance sheet. At December 31, 2016, these reserves were $16,703, of which $15,441 is included in “Other non-current liabilities” on the Company’s balance sheet. The increase in the reserves includes adjustments to reserves of $2,419, partially offset by payments of $1,688. The reserves are adjusted periodically as remediation efforts progress or as additional technical, regulatory or legal information becomes available. Given the uncertainties regarding the outcome of investigative and study activities, the status of laws, regulations, enforcement, policies, the impact of other PRPs, technology and information related to individual sites, the Company does not believe it is possible to currently develop an estimate of the range of reasonably possible environmental loss in excess of its reserves.

Bayonne

As a result of the sale of a Bayonne, New Jersey facility, the Company became obligated to investigate site conditions and conduct required remediation under the New Jersey Industrial Site Recovery Act. The Company has implemented a sampling plan at the property pursuant to the New Jersey Department of Environmental Protection’s (“NJDEP”) private oversight program. The results will be used to develop a remedial plan for the site including an estimate of the Company’s future liability for remediation costs. As of September 30, 2017, the Company’s reserve was $450.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(11)	Contingencies (continued)

Clifton and Carlstadt

The Company has implemented a sampling and pilot program in Clifton and Carlstadt, New Jersey pursuant to the NJDEP private oversight program. The results of the sampling and pilot program to date have been used to develop an estimate of the Company's future liability for remediation costs, and the Company continues to move forward with the projects at each site in accordance with the established schedules and work plans. As of September 30, 2017, the Company’s reserve was $1,889.

Berry’s Creek

The Company received a notice from the United States Environmental Protection Agency (“USEPA”) that two subsidiaries of the Company are considered PRPs at the Berry’s Creek Study Area in New Jersey. These subsidiaries are among many other PRPs that were listed in the notice. Pursuant to the notice, the PRPs have been asked to perform a remedial investigation (“RI”) and feasibility study (“FS”) of the Berry’s Creek site. The Company has joined the group of PRPs and entered into an Administrative Settlement Agreement (“Agreement”) and Order on Consent with the USEPA agreeing to jointly conduct or fund an appropriate remedial investigation and feasibility study of the Berry’s Creek site with the other PRPs in the Agreement. The PRPs have engaged consultants to perform the work specified in the Agreement and develop a method to allocate related costs among the PRPs.

In June 2016, the PRPs received a request from USEPA to amend the RI/FS Work Plan to accommodate a phased, iterative approach to the Berry’s Creek remediation. USEPA requested an initial interim remedy that focuses on a portion of the site, namely, sediments in Upper and Middle Berry’s Creek and the marsh in Upper Peach Island Creek. Any subsequent remedial action will occur after the implementation and performance monitoring of this interim remedy and the extent of future action is expected to be at least partially determined by the outcome of this initial phase. In April 2017, USEPA approved the requested addendum to the RI/FS Work Plan, which included the description of the phased and adaptive management approach to the Berry’s Creek remedy.

The scope of remedial activities in the initial interim remedy is currently being developed and based upon preliminary cost estimates, the Company’s reserve was $9,829 as of September 30, 2017. The estimated costs for the initial interim remedy may be further developed over the next several months and the Company’s accrual may change based upon the final remedy selected and revisions to cost estimates. At this time it is not known when the costs for the complete remediation plan will be estimable, and as such, no accrual beyond the initial interim remedy has been recorded. The Company’s share has been preliminarily estimated by the PRP group at 2.4%. While the Company will defend its position that its share should be reduced from the current level, its share could be increased or decreased depending on the outcome of the final allocation process that will take place in future periods.

While any resolution of this matter is not expected to materially impact the Company’s operations or financial position, it could be material to the financial statements in the period recorded.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(11)	Contingencies (continued)

In July 2014, the Company received a notice from the U.S. Department of the Interior, U.S. Fish & Wildlife Service, regarding the Company’s potential liability for natural resource damages at the Berry’s Creek site and inviting the Company to participate in a cooperative assessment of natural resource damages. Most members of the Berry’s Creek PRP group received such notice letters, and the PRP Group coordinated a joint response, which was to decline participation in a cooperative assessment at this time, given existing investigation work at the site. The cost of any future assessment and the ultimate scope of natural resource damage liability are not yet known.

Maybrook Site

A subsidiary of Cambrex is named a PRP of a site in Hamptonburgh, New York by the USEPA in connection with the discharge, under appropriate permits, of wastewater at that site prior to Cambrex's acquisition in 1986. The PRPs implemented soil remediation which was completed in 2012 pending approval by the USEPA. The PRPs will continue implementing the ground water remediation at the site. In May 2017, the Company made a payment to USEPA in the amount of $363 for ongoing oversight costs. As of September 30, 2017, the Company’s reserve was $329, to cover long-term ground water monitoring and related costs.

Harriman Site

Subsidiaries of Cambrex and Pfizer are named as responsible parties for the Company’s former Harriman, New York production facility by the New York State Department of Environmental Conservation (“NYSDEC”). A final Record of Decision (“ROD”) describing the Harriman site remediation responsibilities for Pfizer and the Company was issued in 1997 (the “1997 ROD”) and incorporated into a federal court Consent Decree in 1998 (the “Consent Decree”). In December 2013, the Company, Pfizer and the NYSDEC entered into a federal court stipulation, which the court subsequently endorsed as a court order, resolving certain disputes with the NYSDEC about the scope of the obligations under the Consent Decree and the 1997 ROD, and requiring the Company and Pfizer to carry out an environmental investigation and study of certain areas of the Harriman Site.

Site clean-up work under the 1997 ROD, the Consent Decree and the 2013 stipulation is ongoing and is being jointly performed by Pfizer and the Company, with NYSDEC oversight. Since 2014, Pfizer and the Company have performed supplemental remedial investigation measures requested by the NYSDEC, and the findings have been submitted to NYSDEC in various reports, including a study evaluating the feasibility of certain remedial alternatives in August 2016. By letter dated January 5, 2017, NYSDEC disapproved such feasibility study report and requested certain revisions to the report. The Company and Pfizer engaged in further discussions with NYSDEC and have agreed to submit a revised version of the August 2016 feasibility study to address certain of NYSDEC’s requests. In September 2017, the NYSDEC requested that Pfizer, the Company and the current owner of the Harriman Site, ELT Harriman LLC (“ELT”), conduct an investigation of additional constituents not addressed under the 1997 ROD based on the detection of those constituents at the Harriman Site and other properties in the area. The parties have requested more information from the State of New York to evaluate the request.

As it is too soon to determine whether the NYSDEC’s requests or the reports and remedial plans, when finalized, will result in any significant changes to the Company’s responsibilities, no change to the reserve has been made. ELT is conducting other investigation and remediation activities under a separate NYSDEC directive.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(11)	Contingencies (continued)

No final remedy for the site has been determined, which will follow further discussions with the NYSDEC. The Company estimates the range for its share of the liability at the site to be between $2,000 and $7,000. As of September 30, 2017, the Company’s reserve was $3,465. At this time, the Company is unable to provide an estimate of the ultimate investigative and remedial costs to the Company for any final remedy selected by the NYSDEC.

The Company intends to enforce all of its contractual rights to recover costs and for indemnification under a 2007 settlement agreement, and has filed such claims in an arbitration proceeding against ELT and the immediately preceding owner, Vertellus Specialties Holdings (“Vertellus”). ELT has filed counterclaims, and has threatened to file additional counterclaims, for contractual indemnification and for breach of the settlement agreement against the Company. Currently, the arbitration proceeding is stayed indefinitely. In May 2016, some but not all of the Vertellus entities who are parties to the Company’s 2007 settlement agreement filed for restructuring under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. The Company has filed several claims as creditors in the bankruptcy proceeding and will continue to monitor the bankruptcy proceeding.

Scientific Chemical Processing (“SCP”) Superfund Site

A subsidiary of Cambrex was named a PRP of the SCP Superfund site, located in Carlstadt, New Jersey, along with approximately 130 other PRPs. The site is a former waste processing facility that accepted various waste for recovery and disposal including processing wastewater from this subsidiary. The PRPs are in the process of implementing a final remedy at the site. The SCP Superfund site has also been identified as a PRP in the Berry’s Creek Superfund site (see previous discussion). While the Company continues to dispute the methodology used by the PRP group to arrive at its interim allocation for cash contributions, the Company has paid the funding requests. A final allocation of SCP Site costs (excluding Berry’s Creek costs) is expected to be finalized in early 2018. As of September 30, 2017, the Company’s reserve was $762, of which approximately $488 is expected to be covered by insurance.

Newark Bay Complex

The USEPA and a private party group are evaluating remediation plans for the Passaic River, Newark Bay, Hackensack River, Arthur Kill, Kill Van Kull and adjacent waters (the “Newark Bay Complex”). Although the Company is not involved in the USEPA action, it continues to monitor developments related to the site due to its past involvement in a previously settled state action relating to the Newark Bay Complex. The USEPA has finalized its decision on a cleanup plan for 8.3 miles of the lower Passaic River, and has estimated the cost of this plan at $1.38 billion. Due to the uncertainty of the future scope and timing of any possible claims against the Company, no liability has been recorded.

The Company is involved in other related and unrelated environmental matters where the range of liability is not reasonably estimable at this time and it is not foreseeable when information will become available to provide a basis for adjusting or recording a reserve, should a reserve ultimately be required.

Litigation and Other Matters

Lorazepam and Clorazepate

In 1998, the Company and a subsidiary were named as defendants along with Mylan Laboratories, Inc. (“Mylan”) and Gyma Laboratories, Inc. (“Gyma”) in a proceeding instituted by the Federal Trade Commission in the United States District Court for the District of Columbia (the “District Court”). Suits were also commenced by several State Attorneys General and class action complaints by private plaintiffs in various state courts. The suits alleged violations of the Federal Trade Commission Act arising from exclusive license agreements between the Company and Mylan covering two APIs (Lorazepam and Clorazepate).

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(in thousands, except share data)

(Unaudited)

(11)	Contingencies (continued)

All cases have been resolved except for one brought by four health care insurers. In the remaining case, the District Court entered judgment after trial in 2008 against Mylan, Gyma and Cambrex. The judgment was appealed to the United States Court of Appeals for the District of Columbia Circuit (the “D.C. Circuit”) in 2011, resulting in a remand to the District Court. On remand, the District Court dismissed certain self-funded customer plaintiffs due to their failure to satisfy the requirements of federal jurisdiction. Subsequently, the District Court entered an order remitting certain damages. Without fees, costs, or post-judgment interest, the current judgment against Mylan, Gyma, and Cambrex is $67,260. Mylan, Gyma, and Cambrex have once again appealed to the D.C. Circuit and the appeal is currently pending.

In 2003, Cambrex paid $12,415 to Mylan in exchange for a release and full indemnity against future costs or liabilities in related litigation brought by the purchasers of Lorazepam and Clorazepate, as well as potential future claims related to the ongoing matter. In the event of a final settlement or final judgment, Cambrex expects any payment required by the Company to be made by Mylan under the indemnity described above.

(12)	Discontinued Operations

For all periods presented, financial results for discontinued operations relate to environmental investigation and remediation expenses for divested sites. The following table is a reconciliation of the pre-tax income/(loss) on discontinued operations to the net income/(loss) on discontinued operations, as presented on the income statement:

	Three months ended September 30,						Nine months ended September 30,
	2017			2016			2017			2016

Pre-tax income/(loss) from discontinued operations	$	126		$	(6,928	)	$	(1,946	)	$	(7,819	)
Income tax (expense)/benefit		(106	)		2,425			622			2,737
Income/(loss) from discontinued operations, net of tax	$	20		$	(4,503	)	$	(1,324	)	$	(5,082	)

As of September 30, 2017 and December 31, 2016, liabilities recorded on the Company’s balance sheet related to discontinued operations were $17,434 and $16,703, respectively. At this time, the Company cannot reasonably estimate the period of time during which the involvement is expected to continue. Net cash used in discontinued operations for the nine months ended September 30, 2017 and 2016 were $1,185 and $312, respectively. Refer to Note 11 to the Company’s consolidated financial statements for further disclosures on the Company’s environmental contingencies.

Table of Contents

CAMBREX CORPORATION AND SUBSIDIARIES

(in thousands, except share data)

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Executive Overview

The following summarizes the Company’s performance for the third quarter of 2017:

●

Net revenue increased 13.3% on a reported basis compared to the third quarter of 2016. Net revenue, excluding currency impact, increased 12.2%.

●

Gross margins increased to 41.6% from 37.8% in the third quarter of 2016.

●

Net cash was $118,403 compared to $74,141 at December 31, 2016, an increase of $44,262.

Results of Operations

Comparison of Third Quarter 2017 versus Third Quarter 2016

Gross sales in the third quarter of 2017 of $112,233 were $12,366 or 12.4% higher than the third quarter of 2016. Excluding a 1.2% favorable impact of foreign exchange compared to the third quarter of 2016, sales increased 11.2% as a result of higher volumes (12.3%) partially offset by lower pricing (1.1%). The increase in volumes was driven by growth in all product categories as well as the addition of Cambrex High Point.

The following table reflects gross sales by geographic area for the third quarters of 2017 and 2016:

	Third quarter
	2017		2016

Europe	$	62,199	$	60,903
North America		44,792		31,414
Asia		2,864		4,645
Other		2,378		2,905
Total gross sales	$	112,233	$	99,867

Net revenue in the third quarter of 2017 of $112,619 was $13,220 or 13.3% higher than the third quarter of 2016. Excluding a 1.1% favorable impact of foreign exchange compared to the third quarter of 2016, net revenue increased 12.2%. The increase was the result of higher volumes as described above.

Gross margins in the third quarter of 2017 increased to 41.6% from 37.8% in the third quarter of 2016. The increase was primarily driven by high capacity utilization, manufacturing efficiency improvements and favorable product mix partially offset by lower pricing. Gross profit in the third quarter of 2017 was $46,889 compared to $37,602 in the same period last year.

Selling, general and administrative (“SG&A”) expenses of $17,551 in the third quarter of 2017 increased compared to $14,950 in the third quarter of 2016. The increase was mainly due to the addition of Cambrex High Point (approximately $1,200), medical expenses (approximately $400) and due diligence costs related to acquisition opportunities (approximately $300). SG&A, as a percentage of net revenue, was 15.6% and 15.0% in the third quarters of 2017 and 2016, respectively.

Table of Contents

Results of Operations (continued)

Comparison of Third Quarter 2017 versus Third Quarter 2016 (continued)

Research and development (“R&D”) expenses of $4,233 were 3.8% of net revenue in the third quarter of 2017, compared to $3,193 or 3.2% of net revenue in the third quarter of 2016. The increase was primarily driven by costs to develop new generic drug products.

Operating profit in the third quarter of 2017 was $25,105 compared to $19,459 in the third quarter of 2016. The increase in operating profit was due to higher gross profit partially offset by higher operating expenses as described above.

Net interest expense was $337 in the third quarter of 2017 compared to $366 in the third quarter of 2016. The Company did not have any debt outstanding as of September 30, 2017 and 2016.

Income tax expense from continuing operations in the third quarter of 2017 was $7,498 compared to $5,443 in the third quarter of 2016. The effective tax rate in the third quarter of 2017 was 30.3% compared to 28.4% in the third quarter of 2016. Tax expense in the third quarter of 2017 was favorably impacted by $735 from the adoption of ASU 2016-09. The standard requires recognition immediately in the tax provision of certain results of share-based payments that were possibly deferred under the previous guidance. Excluding the effects of applying the new standard, the effective tax rate for the three months ended September 30, 2017 was 33.2%.

Income from continuing operations in the third quarter of 2017 was $17,276, or $0.52 per diluted share, versus $13,721, or $0.42 per diluted share in the same period a year ago.

Comparison of First Nine Months of 2017 versus First Nine Months of 2016

Gross sales in the first nine months of 2017 of $350,431 were $37,575 or 12.0% higher than the first nine months of 2016. Excluding a 0.6% unfavorable impact of foreign exchange compared to the first nine months of 2016, sales increased 12.6% as a result of higher volumes (14.9%) partially offset by lower pricing (2.3%). The increase in volumes was driven by growth in all product categories as well as the addition of Cambrex High Point, partially offset by the divestiture of Zenara.

The following table reflects gross sales by geographic area for the first nine months of 2017 and 2016:

	First nine months
	2017		2016

Europe	$	197,503	$	184,852
North America		132,286		105,646
Asia		13,072		13,459
Other		7,570		8,899
Total gross sales	$	350,431	$	312,856

Net revenue in the first nine months of 2017 of $352,179 was $39,401 or 12.6% higher than the first nine months of 2016. Excluding a 0.9% unfavorable impact of foreign exchange compared to the first nine months of 2016, net revenue increased 13.5%. The increase was the result of higher volumes as described above and royalties of $1,000 recorded as “Other revenues, net” in the Company’s income statement.

Table of Contents

Comparison of First Nine Months of 2017 versus First Nine Months of 2016 (continued)

Gross margins in the first nine months of 2017 increased to 42.9% from 40.0% in the first nine months of 2016. The increase was primarily due to plant efficiencies, high capacity utilization and royalty income partially offset by lower pricing. Gross profit in the first nine months of 2017 was $151,216 compared to $125,058 in the same period last year.

Selling, general and administrative (“SG&A”) expenses of $51,785 in the first nine months of 2017 increased compared to $42,602 in the first nine months of 2016. The increase was mainly due to the addition of Cambrex High Point (approximately $3,300), higher personnel costs (approximately $2,400), medical expenses (approximately $1,800) and due diligence costs related to acquisition opportunities (approximately $700). SG&A, as a percentage of net revenue, was 14.7% and 13.6% in the first nine months of 2017 and 2016, respectively.

Research and development (“R&D”) expenses of $12,590 were 3.6% of net revenue in the first nine months of 2017, compared to $10,796 or 3.5% of net revenue in the first nine months of 2016. The increase was primarily related to lower absorption of R&D expenses into inventory and cost of goods sold and higher costs to develop new generic drug products.

Operating profit in the first nine months of 2017 was $86,841 compared to $71,660 in the first nine months of 2016. The increase in operating profit was due to higher gross profit partially offset by higher operating expenses as described above.

Net interest expense was $991 in the first nine months of 2017 compared to $357 in the first nine months of 2016. Higher interest expense was the result of higher amortization of debt issuance costs, higher commitment fees related to the new credit facility entered into during the second quarter of 2016 and lower capitalized interest as a result of the completion of several large projects in 2016. The Company did not have any debt outstanding as of September 30, 2017 and 2016.

Income tax expense from continuing operations in the first nine months of 2017 was $22,484 compared to $21,784 in the first nine months of 2016. The effective tax rate in the first nine months of 2017 was 26.1% compared to 30.6% in the first nine months of 2016. Tax expense in the first nine months of 2017 was favorably impacted by $5,114 from the adoption of ASU 2016-09. The standard requires recognition immediately in the tax provision of certain results of share-based payments that were possibly deferred under the previous guidance. Excluding the effects of applying the new standard, the effective tax rate for the nine months ended September 30, 2017 was 32.1%.

Income from continuing operations in the first nine months of 2017 was $63,515, or $1.90 per diluted share, versus $49,376, or $1.50 per diluted share in the same period a year ago.

Table of Contents

Liquidity and Capital Resources

During the first nine months of 2017, cash provided by operations was $72,085 versus $114,793 in the same period a year ago. This decrease was primarily due to a $39,000 advance payment received in the first quarter of 2016.

Cash flows used in investing activities in the first nine months of 2017 mostly related to capital expenditures of $38,241 compared to $37,706 in the same period a year ago. Capital expenditures in the first nine months of 2017 and 2016 primarily expanded the Company’s manufacturing capacity to support expected growth.

Cash flows provided by financing activities in the first nine months of 2017 were $3,448 compared to $30,399 used in financing activities in the same period a year ago. The 2016 cash flows primarily relate to the pay down of the Company’s debt.

The Company expects to spend approximately $65,000 to $70,000 on capital expenditures during 2017.

The Company has a $500,000 Senior Credit Facility. Borrowings under the Credit Facility bear interest at a rate per annum of LIBOR plus a margin ranging from 1.25% to 2%. The facility is currently undrawn.

The Company believes that cash flows from operations, along with funds available from the revolving line of credit, will be adequate to meet the operational and debt servicing needs of the Company for the foreseeable future.

The Company’s forecasted cash flow from future operations may be adversely affected by various factors including, but not limited to, declines in customer demand, increased competition, the deterioration in general economic and business conditions, increased environmental remediation, returns on assets within the Company’s domestic pension plans, as well as other factors. Our largest product (31.6% of 2016 sales), is used by our customer to produce an anti-viral drug. Our customer's sales of this drug have been trending downwards and, accordingly, we expect our sales of this product to our customer to also trend downwards over the next few years.

As discussed more fully in Note 11 to the Consolidated Financial Statements, the Company continually receives additional information to develop estimates to record reserves for remediation activities at Berry’s Creek and other environmental sites. These matters, either individually or in the aggregate, could result in actual costs that are significantly higher than the Company’s current assessment and could have a material adverse effect on the Company's cash flows in future reporting periods. Based upon past experience, the Company believes that payments significantly in excess of current reserves, if required, would be made over an extended number of years.

See the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the period ended December 31, 2016 for further explanation of factors that may negatively impact the Company’s cash flows.

Table of Contents

Impact of Recent Accounting Pronouncements

The following accounting pronouncements became effective for the Company in the first nine months of 2017:

Simplification of Employee Share-Based Payment Accounting

Simplifying the Measurement of Inventory

The following recently issued accounting pronouncements will become effective for the Company in the future:

Business Combinations – Clarifying the Definition of a Business

Statement of Cash Flows – Restricted Cash

Table of Contents

Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments

Leases

Revenue from Contracts with Customers

Table of Contents

Presentation of Net Periodic Benefit Cost Related to Defined Benefit Plans

Simplifying the Test for Goodwill Impairment

Scope of Modification Accounting, Stock Based Compensation

Targeted Improvements to Accounting for Hedging Activities

Table of Contents

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

There has been no significant change in the Company’s exposure to market risk during the first nine months of 2017. For a discussion of the Company’s exposure to market risk, refer to Part II, Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” contained in the Company’s Annual Report on Form 10-K for the period ended December 31, 2016.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) under the Securities Exchange Act of 1934 (the “Exchange Act”), the Company carried out an evaluation, under the supervision and with the participation of management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this Form 10-Q. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during the quarter covered by this report that has materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II - OTHER INFORMATION

CAMBREX CORPORATION AND SUBSIDIARIES

Item 1.

Legal Proceedings

See the discussion under Part I, Item 1, Note 11 to the Company’s Consolidated Financial Statements.

Item 1A.

Risk Factors

There have been no material changes to the Company’s risk factors and uncertainties during the first nine months of 2017. For a discussion of the Risk Factors, refer to Part I, Item 1A, “Risk Factors,” contained in the Company’s Annual Report on Form 10-K for the period ended December 31, 2016.

Item 6.

Exhibits

	Exhibit 31.1*	Section 302 Certification Statement of the Chief Executive Officer.

	Exhibit 31.2*	Section 302 Certification Statement of the Chief Financial Officer.

	Exhibit 32**	Section 906 Certification Statements of the Chief Executive Officer and Chief Financial Officer.

	Exhibit 101.INS*	XBRL Instance Document

	Exhibit 101.SCH*	XBRL Taxonomy Extension Schema

	Exhibit 101.CAL*	XBRL Taxonomy Extension Calculation Linkbase

	Exhibit 101.DEF*	XBRL Taxonomy Extension Definition Linkbase

	Exhibit 101.LAB*	XBRL Taxonomy Extension Label Linkbase

	Exhibit 101.PRE*	XBRL Taxonomy Extension Presentation Linkbase

	* Filed herewith
	** Furnished herewith

Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language): (i) Consolidated Balance Sheets as of September 30, 2017 and December 31, 2016, (ii) Consolidated Income Statements for the three and nine months ended September 30, 2017 and 2016, (iii) Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2017 and 2016, (iv) Consolidated Statements of Cash Flows for the nine months ended September 30, 2017 and 2016, and (v) Notes to Consolidated Financial Statements.

Table of Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		CAMBREX CORPORATION


	By	/s/Tom G. Vadaketh
		Tom G. Vadaketh
		Executive Vice President and Chief Financial Officer (On behalf of the Registrant and as the Registrant's Principal Financial Officer)

Dated: November 7, 2017

EX-31.1 2 ex_98443.htm EXHIBIT 31.1 ex_98443.htm

Exhibit 31.1

Cambrex Corporation

Certification Pursuant to Rule 13a – 14(a) and Rule 15d – 14(a)

of the Securities Exchange Act, as Amended

I, Steven M. Klosk, certify that:

I have reviewed this quarterly report on Form 10-Q of Cambrex Corporation;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15 (f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	/s/Steven M. Klosk
	Steven M. Klosk
	President and Chief Executive Officer

Dated: November 7, 2017

EX-31.2 3 ex_98444.htm EXHIBIT 31.2 ex_98444.htm

Exhibit 31.2

Cambrex Corporation

Certification Pursuant to Rule 13a – 14(a) and Rule 15d – 14(a)

of the Securities Exchange Act, as Amended

I, Tom G. Vadaketh, certify that:

I have reviewed this quarterly report on Form 10-Q of Cambrex Corporation;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	/s/Tom G. Vadaketh
	Tom G. Vadaketh
	Executive Vice President and
	Chief Financial Officer

Dated: November 7, 2017

EX-32 4 ex_98445.htm EXHIBIT 32 ex_98445.htm

Exhibit 32

CAMBREX CORPORATION

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Cambrex Corporation (the “Company”) on Form 10-Q for the period ending September 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his respective knowledge:

The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	/s/Steven M. Klosk
	Steven M. Klosk
	President and Chief Executive Officer

	/s/Tom G. Vadaketh
	Tom G. Vadaketh
	Executive Vice President and Chief Financial Officer

Dated: November 7, 2017

EX-101.INS 5 cbm-20170930.xml XBRL INSTANCE DOCUMENT 1380000000 225000 565000 1468000 1901000 -355000 -1048000 -288000 -867000 1087000 7838000 0.321 0.024 2418000 6748000 67260000 130 2 611000 97000 3216000 1823000 12415000 821000 637000 2534000 1947000 39037 19598 21.02 18.37 8.3 2000000 7000000 0 false --12-31 Q3 2017 2017-09-30 10-Q 0000820081 32777576 Yes Large Accelerated Filer CAMBREX CORP No Yes cbm 37626000 20896000

39874000

42873000

81776000

110622000

17434000

16881000

16703000

15441000

450000

1889000

9829000

329000

3465000

762000

1688000

363000

2419000

35856000

35614000

-45030000

-65520000

P3Y

P7Y

P20Y

P10Y

P15Y

P3Y

P7Y

P20Y

P10Y

P15Y

162140000

153681000

477000

1375000

227000

614000

698351000

611865000

378082000

322655000

74141000

43974000

118403000

90736000

44262000

46762000

-1185000

-312000

0.10

100000000

34207225

33927595

3421000

3393000

24552000

9655000

82681000

45847000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 27pt;"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">(</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></div><div style="display: inline; font-weight: bold;">) </div></div></div> </td> <td> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Accumulated Other Comprehensive Income</div><div style="display: inline; font-weight: bold;">/(Loss)</div></div></div> </td> </tr> </table> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The following table<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">s provide the changes in AOCI by component (pension, net of tax) for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016:</div></div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Foreign</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Currency</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Translation</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Adjustments</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Pension</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Plans</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 55%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of June 30, 2017</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(21,543</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(30,743</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(52,286</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Other comprehensive income before reclassifications</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,006</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,006</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Amounts reclassified from accumulated other comprehensive loss</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt;">Net current-period other comprehensive income</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,006</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,256</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of September 30, 2017</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(14,537</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(30,493</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(45,030</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Foreign</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Currency</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Translation</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Adjustments</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Pension</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Plans</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 55%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of June 30, 2016</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(25,168</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(29,165</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(54,333</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Other comprehensive income before reclassifications</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">235</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">235</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Amounts reclassified from accumulated other comprehensive loss</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">202</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">202</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net current-period other comprehensive income</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">235</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">202</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">437</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of September 30, 2016</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(24,933</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(28,963</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(53,896</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The following tables provide the changes in AOCI by component <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">(pension, net of tax) for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016:</div></div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Foreign</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Currency</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Translation</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Adjustments</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Pension</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Plans</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 55%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of December 31, 2016</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(34,290</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(31,230</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(65,520</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Other comprehensive income before reclassifications</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,753</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,753</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Amounts reclassified from accumulated other comprehensive loss</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">737</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">737</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net current-period other comprehensive income</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,753</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">737</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,490</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of September 30, 2017</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(14,537</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(30,493</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(45,030</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"></div></div><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"><tr style="vertical-align: top;"><td><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"></div></div></div> </td> </tr> </table> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Foreign</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Currency </div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Translation</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Adjustments</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Pension</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Plans</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 55%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of December 31, 2015</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(25,880</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(29,569</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(55,449</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Other comprehensive income before reclassifications</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">947</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">947</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Amounts reclassified from accumulated other comprehensive loss</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net current-period other comprehensive income</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">947</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,553</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of September 30, 2016</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(24,933</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(28,963</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(53,896</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">The following tables provide the reclassifications from AOCI by component for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016:</div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="width: 70%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Details about AOCI Components</div></div> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three months ended</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30, 2017</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine months ended </div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30, 2017</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amortization of defined benefit pension items:</div> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Actuarial losses</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(355</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,048</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Prior service costs</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(13</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(39</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Total before tax</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(368</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,087</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Tax benefit</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">118</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Net of tax</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(250</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(737</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total reclassification for the period</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(250</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(737</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table> </div> <div style=" margin: 0pt;"> </div> <div style=" margin: 0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Details about AOCI Components</div></div> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three months ended </div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30, 2016</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine months ended </div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30, 2016</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amortization of defined benefit pension items:</div> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Actuarial losses</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(288</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(867</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Prior service costs</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(14</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(39</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Total before tax</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(302</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(906</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Tax benefit</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">300</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Net of tax</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(202</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(606</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total reclassification for the period</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(202</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(606</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company recognizes net periodic benefit cost, which includes amortization of actuarial losses and gains, and prior service costs in both “Selling, general and administrative expenses” and “Cost of goods sold” in its income statement depending on the functional area of the underlying employees included in the plan.</div></div></div>

65730000

61797000

200963000

187720000

8024000

7506000

39000000

10512000

13061000

9103000

6921000

44267000

43109000

-199000

-194000

-599000

-582000

-94000

-49000

-268000

-147000

-1000

-3000

677000

662000

2031000

1986000

553000

597000

1661000

1792000

192000

186000

545000

560000

77000

65000

231000

194000

75000

129000

229000

388000

532000

420000

1510000

1265000

247000

186000

700000

561000

23023000

17717000

193000

125000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 27pt;"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">(</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div></div><div style="display: inline; font-weight: bold;">) </div></div></div> </td> <td> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Stock Based Compensation </div></div></div> </td> </tr> </table> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company recognizes compensation costs for stock option<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">s awarded to employees based on their grant-date fair value. The value of each stock option is estimated on the date of grant using the Black-Scholes option-pricing model. The weighted-average fair value per share for the stock options granted to employees during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$20.14.</div> The weighted-average fair value per share for the stock options granted to employees during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2016 </div>was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$13.82.</div> </div></div> <div style=" margin: 0pt; text-align: justify; text-indent: 22.5pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,187</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,012,</div> respectively, in “Selling, general and administrative expenses” for stock options. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,313</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,836,</div> respectively, in “Selling, general and administrative expenses” for stock options. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>the total compensation cost related to unvested stock options <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet recognized was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7,224.</div> The cost will be amortized on a straight-line basis over the remaining weighted-average vesting period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.9</div> years.</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The following table is a summary of the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">’s stock options: </div></div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="width: 70%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Options</div></div> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares </div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise Price </div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 2016</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,519,338</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25.22</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39,037</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">54.15</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(61,249</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11.83</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at March 31, 2017</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,497,126</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26.52</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,598</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58.98</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(162,431</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13.84</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at June 30, 2017</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,354,293</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28.51</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(55,950</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.48</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at September 30, 2017</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,298,343</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29.37</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable at September 30, 2017</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">449,959</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21.09</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">The aggregate intrinsic values for all stock options exercised for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,669</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$12,011,</div> respectively. The aggregate intrinsic values for all stock options exercised for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2016 </div>were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$173</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8,195,</div> respectively. The aggregate intrinsic values for all stock options outstanding and exercisable as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$33,350</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$15,256,</div> respectively. </div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"></div></div><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"><tr style="vertical-align: top;"><td><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"></div></div></div> </td> </tr> </table> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">The following table is a summary of the Company’s unvested stock options, restricted stock and performance shares for which the requisite service period has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> been rendered but that are expected to vest on the achievement of a performance condition:</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Unvested Stock Options</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Unvested Restricted Stock</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Unvested Performance Shares</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">of Shares</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted-</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Grant-Date </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Fair Value</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted-</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Grant-Date </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Fair Value</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted- </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Grant-Date </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Fair Value</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 28%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at December 31, 2016</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">817,540</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12.50</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">260</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41.05</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">316,750</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30.08</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39,037</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested during period</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(14,975</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.16</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at March 31, 2017</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">841,602</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12.97</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">260</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41.05</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">316,750</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30.08</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,598</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18.37</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,496</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58.98</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,750</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41.36</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested during period</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(12,816</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.50</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(260</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41.05</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at June 30, 2017</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">848,384</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13.17</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,496</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58.98</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">322,500</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30.28</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested during period</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(150,000</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17.81</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at September 30, 2017</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">848,384</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13.17</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,496</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58.98</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">172,500</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41.12</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$280</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$240,</div> respectively, in “Selling, general and administrative expenses” for restricted stock awards. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$474</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$406,</div> respectively, in “Selling, general and administrative expenses” for restricted stock awards. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>total compensation cost related to unvested restricted stock <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet recognized was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$93.</div> The cost will be amortized on a straight-line basis over the remaining weighted-average vesting period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.1</div> years.</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; text-indent: 27pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company granted equity-settled performance shares (“PS”) to certain executives. PS awards provide the recipient the right to receive a certain number of shares of the Company’s common stock in the future, which depends on the Company’s level of achievement of net revenue and EBITDA growth as compared to the net revenue and EBITDA growth of the members of a specified peer group of companies over a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> year period. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$821</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$637,</div> respectively, in “Selling, general and administrative expenses” related to these PS awards. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,534</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,947,</div> respectively, in “Selling, general and administrative expenses” related to these PS awards. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>total compensation cost related to unvested performance shares <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet recognized was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,143.</div> The cost will be amortized on a straight-line basis over the remaining weighted-average vesting period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.3</div> years.</div></div></div>

17434000

16703000

126000

-6928000

-1946000

-7819000

106000

-2425000

-622000

-2737000

0.53

0.29

1.91

1.38

0.52

0.28

1.86

1.35

4134000

61000

-0.06

0.303

0.261

0.284

0.306

7224000

93000

3143000

P1Y328D

P36D

P1Y109D

1535000

1346000

1047000

3928000

829000

1082000

459000

2370000

1881000

2003000

2019000

6971000

3589000

7597000

18157000

6444000

3204000

7522000

17170000

5436000

2243000

6550000

14229000

5615000

2122000

7063000

14800000

193000

125000

40323000

43200000

2877000

46889000

37602000

151216000

125058000

17276000

13721000

63515000

49376000

-368000

-1087000

-302000

-906000

24774000

19164000

85999000

71160000

0.53

0.43

1.95

1.54

0.52

0.42

1.90

1.50

20000

-4503000

-1324000

-5082000

-0.14

-0.04

-0.16

-0.14

-0.04

-0.15

-5114000

7498000

22484000

5443000

21784000

-118000

-350000

-100000

-300000

-16422000

-8504000

-35995000

-44213000

512000

39363000

38245000

40088000

2282000

2764000

70000

2144000

14229000

14800000

-337000

-366000

-991000

-357000

49771000

29117000

164913000

123184000

44355000

33841000

6619000

5763000

64168000

54463000

3217000

5950000

200474000

206438000

698351000

611865000

84217000

95462000

3448000

-30399000

-35405000

-37693000

72085000

114793000

62191000

44294000

-250000

-737000

-250000

-737000

-202000

-606000

-202000

-606000

17296000

9218000

6000

71000

149000

-143000

7006000

235000

19753000

947000

21784000

18143000

64375000

53398000

25105000

19459000

86841000

71660000

3383000

3934000

-118000

-100000

-350000

-300000

7006000

235000

19753000

947000

7006000

250000

7256000

235000

202000

437000

19753000

737000

20490000

947000

606000

1553000

-250000

-202000

-737000

-606000

23887000

21946000

-516000

-265000

7901000

6748000

-13000

2515000

38241000

37706000

5089000

7960000

2958000

2836000

3448000

2116000

248945000

217092000

-250000

-202000

-737000

-606000

4991000

2972000

30000000

4233000

3193000

12590000

10796000

280000

240000

474000

406000

389567000

327376000

112233000

99867000

350431000

312856000

112008000

99302000

348963000

310955000

112619000

99399000

352179000

312778000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Foreign</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Currency</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Translation</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Adjustments</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Pension</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Plans</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 55%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of June 30, 2017</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(21,543</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(30,743</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(52,286</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Other comprehensive income before reclassifications</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,006</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,006</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Amounts reclassified from accumulated other comprehensive loss</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt;">Net current-period other comprehensive income</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,006</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,256</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of September 30, 2017</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(14,537</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(30,493</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(45,030</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Foreign</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Currency</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Translation</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Adjustments</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Pension</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Plans</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 55%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of June 30, 2016</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(25,168</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(29,165</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(54,333</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Other comprehensive income before reclassifications</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">235</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">235</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Amounts reclassified from accumulated other comprehensive loss</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">202</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">202</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net current-period other comprehensive income</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">235</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">202</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">437</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of September 30, 2016</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(24,933</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(28,963</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(53,896</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Foreign</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Currency</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Translation</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Adjustments</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Pension</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Plans</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 55%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of December 31, 2016</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(34,290</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(31,230</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(65,520</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Other comprehensive income before reclassifications</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,753</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,753</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Amounts reclassified from accumulated other comprehensive loss</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">737</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">737</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net current-period other comprehensive income</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,753</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">737</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,490</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of September 30, 2017</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(14,537</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(30,493</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(45,030</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Foreign</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Currency </div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Translation</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Adjustments</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Pension</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Plans</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 55%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of December 31, 2015</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(25,880</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(29,569</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(55,449</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Other comprehensive income before reclassifications</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">947</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">947</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Amounts reclassified from accumulated other comprehensive loss</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net current-period other comprehensive income</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">947</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,553</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Balance as of September 30, 2016</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(24,933</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(28,963</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(53,896</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin: 0pt; text-indent: 0px; font-size: 10pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="width: 44%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 3%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="10" style="width: 21474836.47%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">As of September 30, 2017</div></div></div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 44%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="3" rowspan="1" style="width: 43%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Amortization</div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Period</div><div style="display: inline; font-weight: bold;"> (in years)</div></div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Gross</div></div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Carrying</div></div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Amount</div></div></div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Accumulated Amortization</div></div></div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Net Carrying</div></div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Amount</div></div></div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 44%;"> </td> <td style="width: 4%;"> </td> <td style="width: 3%;"> </td> <td style="width: 4%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 44%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Internal-use software</div> </td> <td style="width: 4%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div></td> <td style="width: 3%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">7</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,971</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,535</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,436</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 44%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Technology-based intangibles</div> </td> <td style="width: 4%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 3%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,589</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,346</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,243</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 44%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Customer-related intangibles</div> </td> <td style="width: 4%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td style="width: 3%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">15</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,597</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,047</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,550</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 44%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 3%; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 4%; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,157</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,928</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,229</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="width: 44%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 3%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="10" style="width: 21474836.47%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">As of December 31, 2016</div></div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 44%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="3" rowspan="1" style="width: 43%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Amortization</div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Period (in years)</div></div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Gross</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Carrying</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Amount</div></div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Accumulated</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Amortization</div></div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Net Carrying</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Amount</div></div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 44%;"> </td> <td style="width: 4%;"> </td> <td style="width: 3%;"> </td> <td style="width: 4%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 44%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Internal-use software</div> </td> <td style="width: 4%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div></td> <td style="width: 3%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">7</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,444</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(829</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,615</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 44%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Technology-based intangibles</div> </td> <td style="width: 4%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 3%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,204</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,082</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,122</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 44%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Customer-related intangibles</div> </td> <td style="width: 4%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td style="width: 3%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" margin: 0pt; text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">15</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,522</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(459</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,063</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 44%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 4%; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 3%; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 4%; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,170</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,370</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,800</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman,Times,serif; font-size: 10pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Unvested Stock Options</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Unvested Restricted Stock</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Unvested Performance Shares</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">of Shares</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted-</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Grant-Date </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Fair Value</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted-</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Grant-Date </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Fair Value</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted- </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Grant-Date </div></div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Fair Value</div></div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 28%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at December 31, 2016</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">817,540</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12.50</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">260</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41.05</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">316,750</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30.08</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39,037</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested during period</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(14,975</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.16</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at March 31, 2017</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">841,602</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12.97</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">260</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41.05</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">316,750</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30.08</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,598</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18.37</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,496</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58.98</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,750</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41.36</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested during period</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(12,816</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.50</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(260</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41.05</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at June 30, 2017</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">848,384</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13.17</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,496</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58.98</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">322,500</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30.28</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested during period</div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(150,000</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17.81</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman,Times,serif; font-size: 10pt;"> <div style=" font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at September 30, 2017</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">848,384</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13.17</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,496</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58.98</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"> </td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">172,500</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41.12</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

-13000

-39000

-14000

-39000

17551000

14950000

51785000

42602000

6321000

5189000

9496

5750

58.98

41.36

260

316750

260

316750

9496

322500

9496

172500

41.05

30.08

41.05

30.08

58.98

30.28

58.98

41.12

260

150000

41.05

17.81

449959

21.09

2669000

12011000

173000

8195000

39037

19598

20.14

13.82

33350000

1519338

1497126

1354293

1298343

25.22

26.52

28.51

29.37

11.83

13.84

8.48

54.15

58.98

15256000

817540

841602

848384

12.50

12.97

13.17

14975

12816

8.16

8.50

488000

61249

162431

55950

1187000

1012000

3313000

2836000

-21543000

-30743000

-52286000

-14537000

-30493000

-45030000

-25168000

-29165000

-54333000

-24933000

-28963000

-53896000

-34290000

-31230000

-65520000

-25880000

-29569000

-55449000

497877000

405427000

463000

9469000

1433649

1583909

12221000

13503000

763

850

839

871

33512

32999

33451

32905

32749

32149

32612

32034

utr:sqmi xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0000820081 cbm:LorazepamAndClorazepateMember us-gaap:IndemnificationGuaranteeMember 2003-01-01 2003-12-31 0000820081 cbm:LorazepamAndClorazepateMember 2008-01-01 2008-12-31 0000820081 2016-01-01 2016-09-30 0000820081 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-09-30 0000820081 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-09-30 0000820081 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-09-30 0000820081 us-gaap:RestrictedStockMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-01-01 2016-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2016-01-01 2016-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2016-01-01 2016-09-30 0000820081 us-gaap:DomesticPlanMember 2016-01-01 2016-09-30 0000820081 us-gaap:ForeignPlanMember 2016-01-01 2016-09-30 0000820081 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2016-01-01 2016-09-30 0000820081 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-01-01 2016-09-30 0000820081 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-09-30 0000820081 us-gaap:AccumulatedTranslationAdjustmentMember 2016-01-01 2016-09-30 0000820081 us-gaap:ComputerSoftwareIntangibleAssetMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0000820081 us-gaap:ComputerSoftwareIntangibleAssetMember us-gaap:MinimumMember 2016-01-01 2016-12-31 0000820081 us-gaap:CustomerContractsMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0000820081 us-gaap:CustomerContractsMember us-gaap:MinimumMember 2016-01-01 2016-12-31 0000820081 cbm:TechnologybasedIntangiblesMember 2016-01-01 2016-12-31 0000820081 2016-07-01 2016-09-30 0000820081 us-gaap:EmployeeStockOptionMember 2016-07-01 2016-09-30 0000820081 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-07-01 2016-09-30 0000820081 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-07-01 2016-09-30 0000820081 us-gaap:RestrictedStockMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-07-01 2016-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-07-01 2016-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-07-01 2016-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2016-07-01 2016-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2016-07-01 2016-09-30 0000820081 us-gaap:DomesticPlanMember 2016-07-01 2016-09-30 0000820081 us-gaap:ForeignPlanMember 2016-07-01 2016-09-30 0000820081 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2016-07-01 2016-09-30 0000820081 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-07-01 2016-09-30 0000820081 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-07-01 2016-09-30 0000820081 us-gaap:AccumulatedTranslationAdjustmentMember 2016-07-01 2016-09-30 0000820081 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-03-31 0000820081 us-gaap:PerformanceSharesMember 2017-01-01 2017-03-31 0000820081 us-gaap:RestrictedStockMember 2017-01-01 2017-03-31 0000820081 2017-01-01 2017-09-30 0000820081 us-gaap:AccountingStandardsUpdate201609Member 2017-01-01 2017-09-30 0000820081 cbm:ReclassificationFromFinancingActivitiesToOperatingActivitiesMember cbm:SixMonthsEndedJune302016Member 2017-01-01 2017-09-30 0000820081 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-09-30 0000820081 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-09-30 0000820081 us-gaap:PerformanceSharesMember 2017-01-01 2017-09-30 0000820081 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-09-30 0000820081 us-gaap:RestrictedStockMember 2017-01-01 2017-09-30 0000820081 us-gaap:RestrictedStockMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-09-30 0000820081 cbm:BerrysCreekSiteMember 2017-01-01 2017-09-30 0000820081 cbm:HarrimanSiteMember us-gaap:MaximumMember 2017-01-01 2017-09-30 0000820081 cbm:HarrimanSiteMember us-gaap:MinimumMember 2017-01-01 2017-09-30 0000820081 cbm:NewarkBayComplexLitigationMember 2017-01-01 2017-09-30 0000820081 cbm:ScientificChemicalProcessingScpSuperfundSiteMember 2017-01-01 2017-09-30 0000820081 us-gaap:ComputerSoftwareIntangibleAssetMember us-gaap:MaximumMember 2017-01-01 2017-09-30 0000820081 us-gaap:ComputerSoftwareIntangibleAssetMember us-gaap:MinimumMember 2017-01-01 2017-09-30 0000820081 us-gaap:CustomerContractsMember us-gaap:MaximumMember 2017-01-01 2017-09-30 0000820081 us-gaap:CustomerContractsMember us-gaap:MinimumMember 2017-01-01 2017-09-30 0000820081 cbm:TechnologybasedIntangiblesMember 2017-01-01 2017-09-30 0000820081 cbm:LorazepamAndClorazepateMember 2017-01-01 2017-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-01-01 2017-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2017-01-01 2017-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2017-01-01 2017-09-30 0000820081 us-gaap:DomesticPlanMember 2017-01-01 2017-09-30 0000820081 us-gaap:ForeignPlanMember 2017-01-01 2017-09-30 0000820081 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2017-01-01 2017-09-30 0000820081 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-01-01 2017-09-30 0000820081 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-09-30 0000820081 us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-01 2017-09-30 0000820081 us-gaap:EmployeeStockOptionMember 2017-04-01 2017-06-30 0000820081 us-gaap:PerformanceSharesMember 2017-04-01 2017-06-30 0000820081 us-gaap:RestrictedStockMember 2017-04-01 2017-06-30 0000820081 cbm:MaybrookSiteMember 2017-05-01 2017-05-30 0000820081 2017-07-01 2017-09-30 0000820081 us-gaap:EmployeeStockOptionMember 2017-07-01 2017-09-30 0000820081 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-07-01 2017-09-30 0000820081 us-gaap:PerformanceSharesMember 2017-07-01 2017-09-30 0000820081 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-07-01 2017-09-30 0000820081 us-gaap:RestrictedStockMember 2017-07-01 2017-09-30 0000820081 us-gaap:RestrictedStockMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-07-01 2017-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-07-01 2017-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-07-01 2017-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2017-07-01 2017-09-30 0000820081 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2017-07-01 2017-09-30 0000820081 us-gaap:DomesticPlanMember 2017-07-01 2017-09-30 0000820081 us-gaap:ForeignPlanMember 2017-07-01 2017-09-30 0000820081 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2017-07-01 2017-09-30 0000820081 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-07-01 2017-09-30 0000820081 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-07-01 2017-09-30 0000820081 us-gaap:AccumulatedTranslationAdjustmentMember 2017-07-01 2017-09-30 0000820081 2015-12-31 0000820081 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2015-12-31 0000820081 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0000820081 us-gaap:AccumulatedTranslationAdjustmentMember 2015-12-31 0000820081 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-06-30 0000820081 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-06-30 0000820081 us-gaap:AccumulatedTranslationAdjustmentMember 2016-06-30 0000820081 2016-09-30 0000820081 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-09-30 0000820081 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-09-30 0000820081 us-gaap:AccumulatedTranslationAdjustmentMember 2016-09-30 0000820081 2016-12-31 0000820081 us-gaap:EmployeeStockOptionMember 2016-12-31 0000820081 us-gaap:PerformanceSharesMember 2016-12-31 0000820081 us-gaap:RestrictedStockMember 2016-12-31 0000820081 us-gaap:OtherNoncurrentLiabilitiesMember 2016-12-31 0000820081 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2016-12-31 0000820081 us-gaap:ForeignExchangeContractMember 2016-12-31 0000820081 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000820081 us-gaap:ComputerSoftwareIntangibleAssetMember 2016-12-31 0000820081 us-gaap:CustomerContractsMember 2016-12-31 0000820081 cbm:TechnologybasedIntangiblesMember 2016-12-31 0000820081 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-12-31 0000820081 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0000820081 us-gaap:AccumulatedTranslationAdjustmentMember 2016-12-31 0000820081 us-gaap:EmployeeStockOptionMember 2017-03-31 0000820081 us-gaap:PerformanceSharesMember 2017-03-31 0000820081 us-gaap:RestrictedStockMember 2017-03-31 0000820081 us-gaap:EmployeeStockOptionMember 2017-06-30 0000820081 us-gaap:PerformanceSharesMember 2017-06-30 0000820081 us-gaap:RestrictedStockMember 2017-06-30 0000820081 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-06-30 0000820081 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-06-30 0000820081 us-gaap:AccumulatedTranslationAdjustmentMember 2017-06-30 0000820081 2017-09-30 0000820081 us-gaap:EmployeeStockOptionMember 2017-09-30 0000820081 us-gaap:PerformanceSharesMember 2017-09-30 0000820081 us-gaap:RestrictedStockMember 2017-09-30 0000820081 us-gaap:OtherNoncurrentLiabilitiesMember 2017-09-30 0000820081 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2017-09-30 0000820081 us-gaap:ForeignExchangeContractMember 2017-09-30 0000820081 cbm:BayonneMember 2017-09-30 0000820081 cbm:BerrysCreekSiteMember 2017-09-30 0000820081 cbm:CliftonAndCarlstadtMember 2017-09-30 0000820081 cbm:HarrimanSiteMember 2017-09-30 0000820081 cbm:MaybrookSiteMember 2017-09-30 0000820081 cbm:NewarkBayComplexLitigationMember 2017-09-30 0000820081 cbm:ScientificChemicalProcessingScpSuperfundSiteMember 2017-09-30 0000820081 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0000820081 us-gaap:ComputerSoftwareIntangibleAssetMember 2017-09-30 0000820081 us-gaap:CustomerContractsMember 2017-09-30 0000820081 cbm:TechnologybasedIntangiblesMember 2017-09-30 0000820081 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-09-30 0000820081 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-30 0000820081 us-gaap:AccumulatedTranslationAdjustmentMember 2017-09-30 0000820081 2017-11-02

EX-101.SCH 6 cbm-20170930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Income Statements (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Comprehensive Income (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Comprehensive Income (Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 006 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 1 - Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 2 - Impact of Recently Issued Accounting Pronouncements link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 3 - Net Inventories link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 4 - Goodwill and Intangible Assets link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 5 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 6 - Derivatives link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 7 - Fair Value Measurements link:calculationLink link:definitionLink link:presentationLink 014 - Document - Note 8 - Accumulated Other Comprehensive Income/(Loss) link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 9 - Stock Based Compensation link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 10 - Retirement Plans link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 11 - Contingencies link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 12 - Discontinued Operations link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 3 - Net Inventories (Tables) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 4 - Goodwill and Intangible Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 7 - Fair Value Measurements (Tables) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 8 - Accumulated Other Comprehensive Income/(Loss) (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 9 - Stock Based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 10 - Retirement Plans (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 12 - Discontinued Operations (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 2 - Impact of Recently Issued Accounting Pronouncements (Details Textual) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 3 - Net Inventories - Schedule of Inventory (Details) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 4 - Goodwill and Intangible Assets (Details Textual) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 4 - Goodwill and Intangible Assets - Change in Carrying Amount of Goodwill (Details) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 4 - Goodwill and Intangible Assets - Summary of Acquired Amortizable Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 5 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 6 - Derivatives (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 7 - Fair Value Measurements - Assets and Liabilities Carried at Fair Value Measured on a Recurring Basi (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 8 - Accumulated Other Comprehensive Income/(Loss) - Changes in Accumulated Other Comprehensive Income (Loss) (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 8 - Accumulated Other Comprehensive Income/(Loss) - Reclassifications Out of Accumulated Other Comprehensive Income (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 9 - Stock Based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 9 - Stock Based Compensation - Summary of Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 9 - Stock Based Compensation - Summary of Nonvested Stock Options, Restricted Stock and Performance Shares (Details) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 10 - Retirement Plans (Details Textual) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 10 - Retirement Plans - Components of Net Periodic Benefit Cost (Details) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 11 - Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 12 - Discontinued Operations (Details Textual) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 12 - Discontinued Operations - Reconciliation of the Pre-tax Loss on Discontinued Operations to the Net Loss on Discontinued Operations (Details) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 7 cbm-20170930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 cbm-20170930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 cbm-20170930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Note To Financial Statement Details Textual statementnote3netinventoriestables statementnote4goodwillandintangibleassetstables statementnote7fairvaluemeasurementstables Foreign Exchange Contract [Member] statementnote8accumulatedothercomprehensiveincomelosstables Type of Adoption [Domain] statementnote9stockbasedcompensationtables Adjustments for New Accounting Pronouncements [Axis] statementnote10retirementplanstables statementnote12discontinuedoperationstables Operating expenses: statementnote3netinventoriesscheduleofinventorydetails statementnote4goodwillandintangibleassetschangeincarryingamountofgoodwilldetails statementnote4goodwillandintangibleassetssummaryofacquiredamortizableintangibleassetsdetails statementnote7fairvaluemeasurementsassetsandliabilitiescarriedatfairvaluemeasuredonarecurringbasidetails statementnote8accumulatedothercomprehensiveincomelosschangesinaccumulatedothercomprehensiveincomelossdetails statementnote8accumulatedothercomprehensiveincomelossreclassificationsoutofaccumulatedothercomprehensiveincomedetails statementnote9stockbasedcompensationsummaryofstockoptionactivitydetails statementnote9stockbasedcompensationsummaryofnonvestedstockoptionsrestrictedstockandperformancesharesdetails statementnote10retirementplanscomponentsofnetperiodicbenefitcostdetails statementnote12discontinuedoperationsreconciliationofthepretaxlossondiscontinuedoperationstothenetlossondiscontinuedoperationsdetails Notes To Financial Statements Foreign currency forwards, assets (liabilities) Notes To Financial Statements [Abstract] Fair Value, Inputs, Level 2 [Member] us-gaap_SiteContingencyRecoveryFromThirdPartyOfEnvironmentalRemediationCost Site Contingency, Recovery from Third Party of Environmental Remediation Cost Fair Value Hierarchy [Domain] Proceeds from stock options exercised Fair Value, Hierarchy [Axis] Cash flows from investing activities: Equity Component [Domain] Report Date [Axis] Equity Components [Axis] Financial Statement Filing Date [Domain] Prepaid Expenses and Other Current Assets [Member] Other Noncurrent Liabilities [Member] Environmental Remediation Contingency [Domain] us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent Pension plan amortization of net actuarial loss and prior service cost, tax us-gaap_IncreaseDecreaseInDeferredRevenue Deferred revenue and advance payments us-gaap_ComprehensiveIncomeNetOfTax Comprehensive income Accounts payable and other current liabilities Environmental Remediation Contingency [Axis] Clifton and Carlstadt [Member] Information about Cosan Clifton, New Jersey site and information about Cosan Carlstadt, New Jersey site. us-gaap_PriorPeriodReclassificationAdjustment Prior Period Reclassification Adjustment Six Months Ended June 30, 2016 [Member] Represents the reporting period for the six month ended June 30, 2016. us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding Diluted (in shares) us-gaap_PaymentsOfDebtIssuanceCosts Debt issuance costs Effect of dilutive stock based compensation (in shares) Legal Matters and Contingencies [Text Block] Bayonne [Member] Represents the Bayonne, New Jersey facility. us-gaap_EarningsPerShareDiluted Net income (in dollars per share) us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income/(loss) from discontinued operations, net of tax (in dollars per share) Berrys Creek Site [Member] Information about Berry's Creek's study area in New Jersey. us-gaap_SalesRevenueNet Net revenue Maybrook Site [Member] Information about Maybrook's site. Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period us-gaap_RepaymentsOfLongTermDebt Repayment of debt us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare Income from continuing operations (in dollars per share) Harriman Site [Member] Information about Harriman's site. Newark Bay Complex Litigation [Member] Information about Newark Bay Complex Litigation. us-gaap_IncomeLossFromContinuingOperationsPerBasicShare Income from continuing operations (in dollars per share) Scientific Chemical Processing SCP Superfund Site [Member] Information about Scientific Chemical Processing (SCP) Superfund Site. Technology-Based Intangibles [Member] Represents acquired technology-based intangible assets. Deferred income tax provision The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to both continuing operations and discontinued operations. cbm_CostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenses Cost of goods sold, selling, general, and administrative expenses Total costs related to goods produced and sold during the reporting period and the aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Diluted earnings/(loss) per share of common stock: Lorazepam and Clorazepate [Member] Suit about violation of the Federal Trade Commission Act arising from exclusive license agreements. Basic (in shares) cbm_PerformanceShareExpense Performance Share Expense The total expense related to equity settled performance shares. Balance Sheet Location [Domain] us-gaap_EarningsPerShareBasic Net income (in dollars per share) Balance Sheet Location [Axis] us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income/(loss) from discontinued operations, net of tax (in dollars per share) Selling, General and Administrative Expenses [Member] Scenario, Unspecified [Domain] Basic earnings/(loss) per share of common stock: Commissions, allowances and rebates Total deductions from sales during the period arising from sales commissions paid to third parties, goods returned by customers and rebates given to certain customers if certain conditions are met. Commissions, allowances and rebates are deductions from gross revenue in arriving at net sales. Scenario [Axis] Other revenues, net Revenues that cover activities outside of, or peripheral to, the central business of the Company; for example, gains and losses resulting from foreign currency transactions. Pension and Other Postretirement Benefits Disclosure [Text Block] cbm_SharebasedPaymentAwardNonvestedStockOptionsWeightedAverageGrantDateFairValueGrantedDuringPeriod Granted, weighted average grant date fair value (in dollars per share) The weighted average fair value as of the grant date of nonvested shares under option plans that were granted during the reporting period as specified in contractual agreements pertaining to the stock option plan. cbm_SharebasedCompensationArrangementByNonvestedSharebasedPaymentAwardsGrantedDuringPeriod Granted, nonvested stock options (in shares) The number of nonvested shares under options that were granted during the reporting period as specified in contractual agreements pertaining to the stock option plan. us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining Discontinued Operation, Amounts of Material Contingent Liabilities Remaining Income Statement Location [Domain] cbm_NumberOfSubsidiariesNoticeReceived Number of Subsidiaries Notice Received Represents the number of subsidiaries for which notice from United States Environmental Protection Agency is received. Income Statement Location [Axis] cbm_SiteContingencyLossExposureEstimatedRange Site Contingency Loss Exposure, Estimated Range Estimated range of the reasonably possible loss exposure for environmental loss contingencies at an individual site. Maximum [Member] cbm_JudgmentAmountAgainstPartiesPayableJointlyAndSeverally Judgment Amount Against Parties Payable Jointly and Severally The amount of judgment against Mylan, Gyma and Cambrex payable jointly and severally. Range [Domain] cbm_NumberOfOtherSitesNamedPrpOfScpSuperfundSite Number of Other Sites Named PRP of SCP Superfund Site Approximate number of sites named potentially responsible parties. Minimum [Member] cbm_AmountOfEstimatedCostToCleanUpSiteThatTheCompanyIsNotExposed Amount of Estimated Cost to Clean Up Site that the Company is Not Exposed The estimated total overall cost of the clean-up plan, the company currently has not been named as a responsible party, but is monitoring due to the uncertainty of the future scope and timing of possible claims against the company. us-gaap_TreasuryStockValue Treasury stock, at cost, 1,433,649 and 1,583,909 shares at respective dates cbm_PaymentInExchangeForReleaseAndFullIndemnityAgainstFutureCostOrLiabilities Payment in Exchange for Release and Full Indemnity Against Future Cost or Liabilities Payments in exchange for release and full indemnity against future cost. Range [Axis] Accounting Policies [Abstract] Statement of Financial Position [Abstract] us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaid expenses and other current assets Statement of Cash Flows [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Non-current liabilities Amount of increase (decrease) in noncurrent liabilities from discontinued operations. us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised Exercised (in shares) us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation Income tax (expense)/benefit us-gaap_IncreaseDecreaseInAccountsReceivable Trade receivables invest_DerivativeNotionalAmount Derivative, Notional Amount Pre-tax income/(loss) from discontinued operations Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Granted (in shares) Disposal Groups, Including Discontinued Operations [Table Text Block] Other non-current liabilities Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] us-gaap_DeferredTaxLiabilitiesNoncurrent Deferred income taxes us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and stockholders' equity Provision for income taxes Income Tax Expense (Benefit) Tax benefit us-gaap_EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent Retained earnings Accumulated other comprehensive loss us-gaap_SalesRevenueGoodsNet Net sales us-gaap_LossContingencyNumberOfPlaintiffs Loss Contingency, Number of Plaintiffs us-gaap_PolicyTextBlockAbstract Accounting Policies Gross sales us-gaap_IncreaseDecreaseInInventories Inventories Deferred income taxes Statement [Table] Advance payments Cash flows from financing activities: Income Statement [Abstract] us-gaap_PaymentsForProceedsFromOtherInvestingActivities Other Accrued pension benefits Class of Stock [Axis] Award Type [Axis] Equity Award [Domain] Customer Contracts [Member] us-gaap_InterestIncomeExpenseNet Interest expense, net Computer Software, Intangible Asset [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Proceeds from sale of business Derivative Instruments and Hedging Activities Disclosure [Text Block] us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Net periodic benefit cost Prepaid expenses and other current assets us-gaap_DefinedBenefitPlanInterestCost Interest cost Service cost us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Amortization of prior service benefit us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets Expected return on plan assets us-gaap_LiabilitiesCurrent Total current liabilities us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses Recognized actuarial loss New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Raw materials Components of net periodic benefit cost Supplies Finished goods us-gaap_NonoperatingIncomeExpense Other (income)/expenses, net Fair Value, Measurements, Recurring [Member] us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet Other non-current assets and liabilities Work in process Indemnification Agreement [Member] us-gaap_OperatingExpenses Total operating expenses Fair Value, Measurement Frequency [Domain] Measurement Frequency [Axis] Changes in assets and liabilities: Share-based Compensation, Stock Options, Activity [Table Text Block] Translation effect us-gaap_OtherNoncashIncomeExpense Other us-gaap_DerivativeFairValueOfDerivativeAsset Derivative Asset, Fair Value, Gross Asset Schedule of Nonvested Share Activity [Table Text Block] Other expenses/(income): Loss Contingency, Nature [Domain] us-gaap_OperatingIncomeLoss Operating profit us-gaap_AccrualForEnvironmentalLossContingencies Accrual for Environmental Loss Contingencies Deferred revenue and advance payments Schedule of Inventory, Current [Table Text Block] Inventory Disclosure [Text Block] Loss Contingency Nature [Axis] us-gaap_GrossProfit Gross profit Litigation Case [Domain] Treasury stock, at cost (in shares) Derivative Contract [Domain] Derivative Instrument [Axis] Schedule of Net Benefit Costs [Table Text Block] Amendment Flag Increase in inventory reserve Litigation Case [Axis] Common stock, $.10 par value; authorized 100,000,000, issued 34,207,225 and 33,927,595 shares at respective dates Other receivables Common stock, shares authorized (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Vested during period, equity awards other than options, weighted average grant date fair value (in dollars per share) EX-101.PRE 10 cbm-20170930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2017	Nov. 02, 2017
Document Information [Line Items]
Entity Registrant Name	CAMBREX CORP
Entity Central Index Key	0000820081
Trading Symbol	cbm
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	Yes
Entity Common Stock, Shares Outstanding (in shares)		32,777,576
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML 12 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 118,403	$ 74,141
Trade receivables, net	81,776	110,622
Other receivables	7,901	6,748
Inventories, net	164,913	123,184
Prepaid expenses and other current assets	5,089	7,960
Total current assets	378,082	322,655
Property, plant and equipment, net	248,945	217,092
Goodwill	43,200	40,323
Intangible assets, net	14,229	14,800
Deferred income taxes	10,512	13,061
Other non-current assets	3,383	3,934
Total assets	698,351	611,865
Current liabilities:
Accounts payable	39,874	42,873
Deferred revenue and advance payments	8,024	7,506
Taxes payable	463	9,469
Accrued expenses and other current liabilities	35,856	35,614
Total current liabilities	84,217	95,462
Advance payments	39,000	39,000
Deferred income taxes	9,103	6,921
Accrued pension benefits	44,267	43,109
Other non-current liabilities	23,887	21,946
Total liabilities	200,474	206,438
Stockholders' equity:
Common stock, $.10 par value; authorized 100,000,000, issued 34,207,225 and 33,927,595 shares at respective dates	3,421	3,393
Additional paid-in capital	162,140	153,681
Retained earnings	389,567	327,376
Treasury stock, at cost, 1,433,649 and 1,583,909 shares at respective dates	(12,221)	(13,503)
Accumulated other comprehensive loss	(45,030)	(65,520)
Total stockholders' equity	497,877	405,427
Total liabilities and stockholders' equity	$ 698,351	$ 611,865

XML 13 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Sep. 30, 2017	Dec. 31, 2016
Common stock par value (in dollars per share)	$ 0.10	$ 0.10
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	34,207,225	33,927,595
Treasury stock, at cost (in shares)	1,433,649	1,583,909

XML 14 R4.htm IDEA: XBRL DOCUMENT

Consolidated Income Statements (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Gross sales	$ 112,233	$ 99,867	$ 350,431	$ 312,856
Commissions, allowances and rebates	225	565	1,468	1,901
Net sales	112,008	99,302	348,963	310,955
Other revenues, net	611	97	3,216	1,823
Net revenue	112,619	99,399	352,179	312,778
Cost of goods sold	65,730	61,797	200,963	187,720
Gross profit	46,889	37,602	151,216	125,058
Operating expenses:
Selling, general and administrative expenses	17,551	14,950	51,785	42,602
Research and development expenses	4,233	3,193	12,590	10,796
Total operating expenses	21,784	18,143	64,375	53,398
Operating profit	25,105	19,459	86,841	71,660
Other expenses/(income):
Interest expense, net	337	366	991	357
Other (income)/expenses, net	(6)	(71)	(149)	143
Income before income taxes	24,774	19,164	85,999	71,160
Provision for income taxes	7,498	5,443	22,484	21,784
Income from continuing operations	17,276	13,721	63,515	49,376
Income/(loss) from discontinued operations, net of tax	20	(4,503)	(1,324)	(5,082)
Net income	$ 17,296	$ 9,218	$ 62,191	$ 44,294
Basic earnings/(loss) per share of common stock:
Income from continuing operations (in dollars per share)	$ 0.53	$ 0.43	$ 1.95	$ 1.54
Income/(loss) from discontinued operations, net of tax (in dollars per share)	0	(0.14)	(0.04)	(0.16)
Net income (in dollars per share)	0.53	0.29	1.91	1.38
Diluted earnings/(loss) per share of common stock:
Income from continuing operations (in dollars per share)	0.52	0.42	1.90	1.50
Income/(loss) from discontinued operations, net of tax (in dollars per share)	0	(0.14)	(0.04)	(0.15)
Net income (in dollars per share)	$ 0.52	$ 0.28	$ 1.86	$ 1.35
Weighted average shares outstanding:
Basic (in shares)	32,749	32,149	32,612	32,034
Effect of dilutive stock based compensation (in shares)	763	850	839	871
Diluted (in shares)	33,512	32,999	33,451	32,905

XML 15 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Net income	$ 17,296	$ 9,218	$ 62,191	$ 44,294
Other comprehensive income:
Foreign currency translation adjustments	7,006	235	19,753	947
Pension plan amortization of net actuarial loss and prior service cost, net of tax of $118, $100, $350 and $300 at respective dates	250	202	737	606
Comprehensive income	$ 24,552	$ 9,655	$ 82,681	$ 45,847

XML 16 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Comprehensive Income (Unaudited) (Parentheticals) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Pension plan amortization of net actuarial loss and prior service cost, tax	$ 118	$ 100	$ 350	$ 300

XML 17 R7.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net income	$ 62,191	$ 44,294
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	23,023	17,717
Non-cash deferred revenue	(4,991)	(2,972)
Increase in inventory reserve	3,217	5,950
Stock based compensation	6,321	5,189
Deferred income tax provision	1,087	7,838
Other	516	265
Changes in assets and liabilities:
Trade receivables	35,995	44,213
Inventories	(38,245)	(40,088)
Prepaid expenses and other current assets	(70)	(2,144)
Accounts payable and other current liabilities	(16,422)	(8,504)
Deferred revenue and advance payments	512	39,363
Other non-current assets and liabilities	(2,282)	(2,764)
Discontinued operations:
Non-current liabilities	2,418	6,748
Net cash used in discontinued operations	(1,185)	(312)
Net cash provided by operating activities	72,085	114,793
Cash flows from investing activities:
Capital expenditures	(38,241)	(37,706)
Proceeds from sale of business	2,836
Other		13
Net cash used in investing activities	(35,405)	(37,693)
Cash flows from financing activities:
Repayment of debt		(30,000)
Proceeds from stock options exercised	3,448	2,116
Debt issuance costs		(2,515)
Net cash provided by/(used in) financing activities	3,448	(30,399)
Effect of exchange rate changes on cash and cash equivalents	4,134	61
Net increase in cash and cash equivalents	44,262	46,762
Cash and cash equivalents at beginning of period	74,141	43,974
Cash and cash equivalents at end of period	$ 118,403	$ 90,736

XML 18 R8.htm IDEA: XBRL DOCUMENT

Note 1 - Basis of Presentation

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

(

)

Basis of

Presentation

Unless otherwise indicated by the context, "Cambrex" or the "Company" means Cambrex Corporation and subsidiaries.

December 31, 2016.

The results of operations of any interim period are

not

necessarily indicative of the results expected for

the full year.

For all periods presented, financial results for discontinued operations relate to environmental

investigation and remediation at sites of divested businesses.

Certain reclassifications have been made to prior year amounts to conform with current year presentation.

XML 19 R9.htm IDEA: XBRL DOCUMENT

Note 2 - Impact of Recently Issued Accounting Pronouncements

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

New Accounting Pronouncements and Changes in Accounting Principles [Text Block]

(

)

Impact of Recently Issued Accounting Pronouncements

The following accounting pronouncements became effective for the Company in the

first

nine

months of

2017:

Simplification of Employee Share-Based Payment Accounting

March 2016,

the FASB issued ASU

2016

which simplifies several aspects of the accounting for

employee share-based payment transactions, including the accounting for income taxes, forfeitures and

classification in the statement of cash flows. This standard became effective for the Company on

January 1,

2017.

The new standard requires recognition of excess tax benefits that had

not

previously been recognized.

The Company had

remaining unrecognized excess tax benefits as of

December 31, 2016.

All excess tax

benefits and deficiencies in future periods will be recorded as part of the current period tax provision within the

Income Statement. This will result in increased volatility in the Company’s effective tax rate. During the

first

nine

months of

2017,

the Company recognized a tax benefit of

$5,114

which lowered the effective tax rate by

6.0%.

other provisions in this new standard had a significant impact on the consolidated financial

statements including the Company’s accounting policy election to account for forfeitures when they occur.

To conform to the current year presentation, the Company reclassified

$2,958

of excess tax benefits

under financing activities to operating activities for the

nine

months ended

September 30, 2016

on the

consolidated statement of cash flows.

Simplifying the Measurement of Inventory

July 2015,

the FASB issued ASU

2015

which requires that inventory be measured at the lower of

cost and net realizable value, and eliminates the other

two

options that currently exist for market, replacement

cost and net realizable value less an approximately normal profit margin. This update became effective on

January 1, 2017

and did

not

have a material impact on the Company’s consolidated financial statements.

The following recently issued accounting pronouncements will become effective for the Company in the future:

Business Combinations – Clarifying the Definition of a Business

January 2017,

the FASB issued ASU

2017

which clarifies the definition of a business to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The standard introduces a screen for determining when assets acquired are

not

a business and clarifies that a business must include, at a minimum, an input and a substantive process that contribute to an output to be considered a business. This standard is effective for fiscal years beginning after

December 15, 2017,

including interim periods within that reporting period. The Company does

not

expect this new guidance to have a material impact on its consolidated financial statements.

Statement of Cash Flows – Restricted Cash

November 2016,

the FASB issued ASU

2016

which clarifies the presentation requirements of restricted cash within the statement of cash flows. The changes in restricted cash and restricted cash equivalents during the period should be included in the beginning and ending cash and cash equivalents balance reconciliation on the statement of cash flows. When cash, cash equivalents, restricted cash or restricted cash equivalents are presented in more than

one

line item within the statement of financial position, an entity shall calculate a total cash amount in a narrative or tabular format that agrees to the amount shown on the statement of cash flows. Details on the nature and amounts of restricted cash should also be disclosed. This standard is effective for fiscal years beginning after

December 15, 2017,

including interim periods within that reporting period. The Company does

not

expect this new guidance to have a material impact on its consolidated financial statements.

Statement of Cash Flows

- Classification of Certain Cash Receipts and Cash Payments

August 2016,

the FASB issued ASU

2016

which provides guidance on the presentation and classification in the statement of cash flows for specific cash receipt and payment transactions, including debt prepayment or extinguishment costs, contingent consideration payments made after a business combination, proceeds from the settlement of insurance claims and corporate-owned life insurance policies, and distributions received from equity method investees. This standard is effective for fiscal years beginning after

December 15, 2017,

including interim periods within that reporting period. The Company does

not

expect this new guidance to have a material impact on its consolidated financial statements.

Leases

February 2016,

the FASB issued ASU

2016

which requires lessees to recognize right of use assets and lease liabilities on the balance sheet for all leases except short-term leases. On the income statement, leases will be classified as operating or finance leases. This standard is effective for fiscal years beginning after

December 15, 2018,

including interim periods within that reporting period. At this time, the Company has

financing leases and only a limited number of operating leases. The result of adoption will be an increase to assets and liabilities by the same amount for the identified operating leases. This adjustment will

not

be material to the Company, assuming there is

not

an increase in lease activity.

Revenue from Contracts with Customers

May 2014,

the FASB issued ASU

2014

that introduces a new

five

-step revenue recognition model in which an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires disclosures sufficient to enable users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers, including qualitative and quantitative disclosures about contracts with customers, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. Numerous updates were issued in

2016

that provide clarification on a number of specific issues as well as requiring additional disclosures. The new standard is effective for fiscal years beginning after

December 15, 2017,

including interim periods within that reporting period. On

January 1, 2018,

the Company will adopt the new accounting standard for all contracts

not

completed as of the adoption date using the modified retrospective method. Certain sales that would have otherwise been reflected in the income statement in

2018

will now be recorded in equity as part of a cumulative effect adjustment. Additionally, a portion of certain products that will be in process at

December 31, 2018

will be eligible for revenue recognition in

2018

as opposed to when they would ship in

2019

under previous guidance.

alternative use, that were previously recognized upon delivery, will be recognized over time utilizing a measure of progress toward satisfaction of the performance obligations. Generally, under these customer agreements, the Company is entitled to compensation for progress to date that includes an element of profit margin. Depending on the amount of these projects in process at the end of

2017,

the cumulative adjustment could be significant, but at this time cannot be reasonably estimated. These products represented nearly half of

2016

net revenue. The Company will also record contract balances on the balance sheet and present all related disclosures in the notes to financial statements. The Company continues to assess the impact of the related disclosures as well as finalizing a methodology and process for recognizing product revenue over time.

Presentation of Net Periodic Benefit Cost Related to Defined Benefit Plans

March 2017,

the FASB issued ASU

2017

which amends the requirements in ASC

715

related to the income statement presentation of the components of net periodic benefit cost for an entity’s sponsored defined pension and other postretirement plans. The ASU requires entities to (

) disaggregate the current-service-cost component from the other components of net benefit cost and present it with other current compensation costs for related employees in the income statement and (

) present the other components elsewhere in the income statement and outside of income from operations if such subtotal is presented. The ASU also requires entities to disclose the income statement lines that contain the other components if they are

not

presented separately. The ASU’s amendment is effective for fiscal years beginning after

December 15, 2017,

including interim periods within that reporting period. The Company does

not

expect this new guidance to have an impact on its consolidated financial statements.

Simplifying the Test for Goodwill Impairment

January 2017,

the FASB issued ASU

2017

which simplifies the goodwill impairment test by eliminating Step

in the determination on whether goodwill should be considered impaired. Instead, an impairment charge should equal the amount by which a reporting unit’s carrying amount exceeds its fair value,

not

to exceed the amount of goodwill allocated to the reporting unit. The new standard is effective for fiscal years beginning after

December 15, 2019,

including interim periods within that reporting period. The Company is currently evaluating the new guidance and does

not

expect it to have an impact on its consolidated financial statements.

Scope of Modification Accounting

, Stock Based Compensation

May 2017,

the FASB issued ASU

2017

which provides clarification on when modification accounting should be used for changes to the terms or conditions of a share-based payment award. This ASU does

not

change the accounting for modifications but clarifies that modification accounting guidance should only be applied if there is a change to the value, vesting conditions, or award classification and would

not

be required if the changes are considered non-substantive.

The amendment is effective for fiscal years beginning after

December 15, 2017,

including interim periods within that reporting period.

The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements.

Targeted Improvements to Accounting for Hedging Activities

August

2017,

the FASB issued ASU

2017

which improves the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. The standard also makes certain targeted improvements to simplify the application of the hedge accounting guidance.

The amendment is effective for fiscal years beginning after

December 15, 2018,

including interim periods within that reporting period.

The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements.

XML 20 R10.htm IDEA: XBRL DOCUMENT

Note 3 - Net Inventories

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Inventory Disclosure [Text Block]

(

)

Net Inventories

Inventories are stated at the lower of cost and net realizable value. Cost is determined on a

first

-in,

first

-out basis.

Net inventories consist of the following:

	September 30,		December 31,
	2017		2016

Finished goods	$	49,771	$	29,117
Work in process		64,168		54,463
Raw materials		44,355		33,841
Supplies		6,619		5,763
Total	$	164,913	$	123,184

XML 21 R11.htm IDEA: XBRL DOCUMENT

Note 4 - Goodwill and Intangible Assets

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Goodwill and Intangible Assets Disclosure [Text Block]

(

)

Goodwill and Intangible Assets

The change in the carrying amount of goodwill for the

nine

months ended

September 30, 2017,

is as follows:

Balance as of December 31, 2016	$	40,323
Translation effect		2,877
Balance as of September 30, 2017	$	43,200

Acquired intangible assets, which are amortized, consist of the following:

				As of September 30, 2017
	Amortization Period (in years)			Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount

Internal-use software	3	-	7	$	6,971	$	(1,535	)	$	5,436
Technology-based intangibles		20			3,589		(1,346	)		2,243
Customer-related intangibles	10	-	15		7,597		(1,047	)		6,550
				$	18,157	$	(3,928	)	$	14,229

				As of December 31, 2016
	Amortization Period (in years)			Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount

Internal-use software	3	-	7	$	6,444	$	(829	)	$	5,615
Technology-based intangibles		20			3,204		(1,082	)		2,122
Customer-related intangibles	10	-	15		7,522		(459	)		7,063
				$	17,170	$	(2,370	)	$	14,800

The change in the gross carrying amount is due to additions and the impact of foreign currency translation.

Amortization expense was

$477

and

$1,375

for the

three

and

nine

months ended

September 30, 2017,

respectively. Amortization expense was

$227

and

$614

for the

three

and

nine

months ended

September 30, 2016,

respectively.

Amortization expense related to intangible assets is expected to be approximately

$1,881

for

2017,

$2,019

for

2018

and

2019,

and

$2,003

for

2020

and

2021.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

XML 22 R12.htm IDEA: XBRL DOCUMENT

Note 5 - Income Taxes

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Income Tax Disclosure [Text Block]

(

)

Income

Taxes

Income

tax expense from continuing operations for the

three

and

nine

months ended

September 30, 2017

was

$7,498

and

$22,484,

respectively, compared to

$5,443

and

$21,784

for the

three

and

nine

months ended

September 30, 2016,

respectively. The effective tax rate for the

three

and

nine

months ended

September 30, 2017

was

30.3%

and

26.1%,

respectively, compared to

28.4%

and

30.6%

for the

three

and

nine

months ended

September 30, 2016,

respectively. Tax expense for the

nine

months ended

September

30,

2017

was favorably impacted by

$5,114

as a result of applying ASU

2016

09.

The standard requires recognition immediately in the tax provision of certain effects of share-based payments that were possibly deferred under the previous guidance. Excluding the effects of applying the new standard, the effective tax rate for the

nine

months ended

September 30, 2017

was

32.1%.

XML 23 R13.htm IDEA: XBRL DOCUMENT

Note 6 - Derivatives

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Derivative Instruments and Hedging Activities Disclosure [Text Block]

(

)

Derivatives

All financial instruments involve market and credit risks. The Company is exposed to credit losses in the event of non-performance by the counterparties to the contracts. While there can be

assurance, the Company does

not

anticipate non-performance by these counterparties.

Foreign Currency Forward Contracts

may

not

elect to designate certain forward contracts for hedge accounting treatment.

For derivatives that are

not

designated for hedge accounting treatment, changes in the fair value are immediately recognized in earnings. This treatment has the potential to increase volatility of the Company’s earnings.

None

of the foreign currency forward contracts entered into during the

nine

months ended

September 30, 2017

and

2016

were designated for hedge accounting treatment. The notional amounts of the Company’s outstanding foreign exchange forward contracts were

$37,626

and

$20,896

September 30, 2017

and

December 31, 2016,

respectively. The Company does

not

hold or purchase any foreign currency forward contracts for trading or speculative purposes and

contractual term is greater than

twelve

months.

The fair value of the Company’s foreign exchange forward contracts outstanding was a gain of

$193

and

$125

September 30, 2017

and

December 31, 2016,

respectively. Losses are recorded in “Accrued expenses and other current liabilities” and gains are recorded in “Prepaid expenses and other current assets” on the balance sheet and “Other revenues, net” on the income statement.

XML 24 R14.htm IDEA: XBRL DOCUMENT

Note 7 - Fair Value Measurements

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Fair Value Disclosures [Text Block]

(

)

Fair Value Measurements

U.S. GAAP establishes a valuation hierarchy for disclosure of the inputs to the valuations used to measure fair value. This hierarchy prioritizes the inputs into

three

broad levels as follows: Level

inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities; Level

inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are

not

active, inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation; Level

inputs are unobservable inputs based on the Company’s assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

The following table provide

s the assets and liabilities carried at fair value, measured on a recurring basis, as of

September 30, 2017

and

December 31, 2016:

Fair Value - Level 2		September 30, 2017				December 31, 2016
Foreign currency forwards, assets		$	193			$	125

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 25 R15.htm IDEA: XBRL DOCUMENT

Note 8 - Accumulated Other Comprehensive Income/(Loss)

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Comprehensive Income (Loss) Note [Text Block]

(

)

Accumulated Other Comprehensive Income

/(Loss)

The following table

s provide the changes in AOCI by component (pension, net of tax) for the

three

months ended

September 30, 2017

and

2016:

	Foreign Currency Translation Adjustments			Pension Plans			Total
Balance as of June 30, 2017	$	(21,543	)	$	(30,743	)	$	(52,286	)
Other comprehensive income before reclassifications		7,006			-			7,006
Amounts reclassified from accumulated other comprehensive loss		-			250			250
Net current-period other comprehensive income		7,006			250			7,256
Balance as of September 30, 2017	$	(14,537	)	$	(30,493	)	$	(45,030	)

	Foreign Currency Translation Adjustments			Pension Plans			Total
Balance as of June 30, 2016	$	(25,168	)	$	(29,165	)	$	(54,333	)
Other comprehensive income before reclassifications		235			-			235
Amounts reclassified from accumulated other comprehensive loss		-			202			202
Net current-period other comprehensive income		235			202			437
Balance as of September 30, 2016	$	(24,933	)	$	(28,963	)	$	(53,896	)

The following tables provide the changes in AOCI by component

(pension, net of tax) for the

nine

months ended

September 30, 2017

and

2016:

	Foreign Currency Translation Adjustments			Pension Plans			Total
Balance as of December 31, 2016	$	(34,290	)	$	(31,230	)	$	(65,520	)
Other comprehensive income before reclassifications		19,753			-			19,753
Amounts reclassified from accumulated other comprehensive loss		-			737			737
Net current-period other comprehensive income		19,753			737			20,490
Balance as of September 30, 2017	$	(14,537	)	$	(30,493	)	$	(45,030	)

	Foreign Currency Translation Adjustments			Pension Plans			Total
Balance as of December 31, 2015	$	(25,880	)	$	(29,569	)	$	(55,449	)
Other comprehensive income before reclassifications		947			-			947
Amounts reclassified from accumulated other comprehensive loss		-			606			606
Net current-period other comprehensive income		947			606			1,553
Balance as of September 30, 2016	$	(24,933	)	$	(28,963	)	$	(53,896	)

The following tables provide the reclassifications from AOCI by component for the

three

and

nine

months ended

September 30, 2017

and

2016:

Details about AOCI Components	Three months ended September 30, 2017			Nine months ended September 30, 2017

Amortization of defined benefit pension items:
Actuarial losses	$	(355	)	$	(1,048	)
Prior service costs		(13	)		(39	)
Total before tax		(368	)		(1,087	)
Tax benefit		118			350
Net of tax	$	(250	)	$	(737	)

Total reclassification for the period	$	(250	)	$	(737	)

Details about AOCI Components	Three months ended September 30, 2016			Nine months ended September 30, 2016

Amortization of defined benefit pension items:
Actuarial losses	$	(288	)	$	(867	)
Prior service costs		(14	)		(39	)
Total before tax		(302	)		(906	)
Tax benefit		100			300
Net of tax	$	(202	)	$	(606	)

Total reclassification for the period	$	(202	)	$	(606	)

XML 26 R16.htm IDEA: XBRL DOCUMENT

Note 9 - Stock Based Compensation

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

(

)

Stock Based Compensation

The Company recognizes compensation costs for stock option

s awarded to employees based on their grant-date fair value. The value of each stock option is estimated on the date of grant using the Black-Scholes option-pricing model. The weighted-average fair value per share for the stock options granted to employees during the

nine

months ended

September 30, 2017

was

$20.14.

The weighted-average fair value per share for the stock options granted to employees during the

nine

months ended

September 30, 2016

was

$13.82.

For the

three

months ended

September 30, 2017

and

2016,

the Company recorded

$1,187

and

$1,012,

respectively, in “Selling, general and administrative expenses” for stock options. For the

nine

months ended

September 30, 2017

and

2016,

the Company recorded

$3,313

and

$2,836,

respectively, in “Selling, general and administrative expenses” for stock options. As of

September 30, 2017,

the total compensation cost related to unvested stock options

not

yet recognized was

$7,224.

The cost will be amortized on a straight-line basis over the remaining weighted-average vesting period of

1.9

years.

The following table is a summary of the Company

’s stock options:

Options	Number of Shares			Weighted Average Exercise Price

Outstanding at December 31, 2016		1,519,338		$	25.22
Granted		39,037			54.15
Exercised		(61,249	)		11.83
Outstanding at March 31, 2017		1,497,126			26.52
Granted		19,598			58.98
Exercised		(162,431	)		13.84
Outstanding at June 30, 2017		1,354,293			28.51
Exercised		(55,950	)		8.48
Outstanding at September 30, 2017		1,298,343			29.37
Exercisable at September 30, 2017		449,959		$	21.09

The aggregate intrinsic values for all stock options exercised for the

three

and

nine

months ended

September 30, 2017

were

$2,669

and

$12,011,

respectively. The aggregate intrinsic values for all stock options exercised for the

three

and

nine

months ended

September 30, 2016

were

$173

and

$8,195,

respectively. The aggregate intrinsic values for all stock options outstanding and exercisable as of

September 30, 2017

were

$33,350

and

$15,256,

respectively.

The following table is a summary of the Company’s unvested stock options, restricted stock and performance shares for which the requisite service period has

not

been rendered but that are expected to vest on the achievement of a performance condition:

	Unvested Stock Options					Unvested Restricted Stock					Unvested Performance Shares
	Number of Shares			Weighted- Average Grant-Date Fair Value		Number of Shares			Weighted- Average Grant-Date Fair Value		Number of Shares			Weighted- Average Grant-Date Fair Value

Unvested at December 31, 2016		817,540		$	12.50		260		$	41.05		316,750		$	30.08
Granted		39,037			21.02		-			-		-			-
Vested during period		(14,975	)		8.16		-			-		-			-
Unvested at March 31, 2017		841,602			12.97		260			41.05		316,750			30.08
Granted		19,598			18.37		9,496			58.98		5,750			41.36
Vested during period		(12,816	)		8.50		(260	)		41.05		-			-
Unvested at June 30, 2017		848,384			13.17		9,496			58.98		322,500			30.28
Vested during period		-			-		-			-		(150,000	)		17.81
Unvested at September 30, 2017		848,384		$	13.17		9,496		$	58.98		172,500		$	41.12

For the

three

months ended

September 30, 2017

and

2016,

the Company recorded

$280

and

$240,

respectively, in “Selling, general and administrative expenses” for restricted stock awards. For the

nine

months ended

September 30, 2017

and

2016,

the Company recorded

$474

and

$406,

respectively, in “Selling, general and administrative expenses” for restricted stock awards. As of

September 30, 2017,

total compensation cost related to unvested restricted stock

not

yet recognized was

$93.

The cost will be amortized on a straight-line basis over the remaining weighted-average vesting period of

0.1

years.

three

year period. For the

three

months ended

September 30, 2017

and

2016,

the Company recorded

$821

and

$637,

respectively, in “Selling, general and administrative expenses” related to these PS awards. For the

nine

months ended

September 30, 2017

and

2016,

the Company recorded

$2,534

and

$1,947,

respectively, in “Selling, general and administrative expenses” related to these PS awards. As of

September 30, 2017,

total compensation cost related to unvested performance shares

not

yet recognized was

$3,143.

The cost will be amortized on a straight-line basis over the remaining weighted-average vesting period of

1.3

years.

XML 27 R17.htm IDEA: XBRL DOCUMENT

Note 10 - Retirement Plans

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Pension and Other Postretirement Benefits Disclosure [Text Block]

(

)

Retirement Plans

Domestic Pension Plan

The components of net periodic

benefit cost for the Company’s domestic pension plan (which was frozen in

2007

) for the

three

and

nine

months ended

September 30, 2017

and

2016

were as follows:

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016

Components of net periodic benefit cost
Interest cost	$	553		$	597		$	1,661		$	1,792
Expected return on plan assets		(677	)		(662	)		(2,031	)		(1,986	)
Recognized actuarial loss		199			194			599			582
Net periodic benefit cost	$	75		$	129		$	229		$	388

The Company’s Supplemental Executive Retirement Plan (which was frozen in

2007

) is non-qualified and unfunded. Net periodic benefit cost for the

three

months ended

September 30, 2017

and

2016

were

$77

and

$65,

respectively. Net periodic benefit cost for the

nine

months ended

September 30, 2017

and

2016

were

$231

and

$194,

respectively.

International Pension Plan

The components of net periodic benefit cost for the Company’s international pension plan for the

three

and

nine

months ended

September 30, 2017

and

2016

were as follows:

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016

Components of net periodic benefit cost
Service cost	$	247		$	186		$	700		$	561
Interest cost		192			186			545			560
Recognized actuarial loss		94			49			268			147
Amortization of prior service benefit		(1	)		(1	)		(3	)		(3	)
Net periodic benefit cost	$	532		$	420		$	1,510		$	1,265

XML 28 R18.htm IDEA: XBRL DOCUMENT

Note 11 - Contingencies

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Legal Matters and Contingencies [Text Block]

(

)

Contingencies

Environmental

It is the Company

’s policy to record appropriate liabilities for environmental matters where remedial efforts are probable and the costs can be reasonably estimated. Such liabilities are based on the Company’s estimate of the undiscounted future costs required to complete the remedial work. Each of these matters is subject to various uncertainties, and it is possible that some of these matters will be decided against the Company. The resolution of such matters often spans several years and frequently involves regulatory oversight or adjudication. Additionally, many remediation requirements are fluid and are likely to be affected by future technological, site and regulatory developments. It is

not

possible at this time for the Company to determine fully the effect of all asserted and unasserted claims on its consolidated financial condition, results of operations or liquidity; however, to the extent possible, where asserted and unasserted claims can be estimated and where such claims are considered probable, the Company would record a liability. Consequently, the ultimate liability with respect to such matters, as well as the timing of cash disbursements, is uncertain.

September 30, 2017,

the reserves were

$17,434,

of which

$16,881

is included in “Other non-current liabilities” on the Company’s balance sheet. At

December 31, 2016,

these reserves were

$16,703,

of which

$15,441

is included in “Other non-current liabilities” on the Company’s balance sheet. The increase in the reserves includes adjustments to reserves of

$2,419,

partially offset by payments of

$1,688.

The reserves are adjusted periodically as remediation efforts progress or as additional technical, regulatory or legal information becomes available. Given the uncertainties regarding the outcome of investigative and study activities, the status of laws, regulations, enforcement, policies, the impact of other PRPs, technology and information related to individual sites, the Company does

not

believe it is possible to currently develop an estimate of the range of reasonably possible environmental loss in excess of its reserves.

Bayonne

September 30, 2017,

the Company’s reserve was

$450.

Clifton and Carlstadt

September 30, 2017,

the Company’s reserve was

$1,889.

Berry

’s Creek

The Company received a notice from the United States Environmental Protection Agency (“USEPA”) that

two

subsidiaries of the Company are considered PRPs at the Berry’s Creek Study Area in New Jersey. These subsidiaries are among many other PRPs that were listed in the notice. Pursuant to the notice, the PRPs have been asked to perform a remedial investigation (“RI”) and feasibility study (“FS”) of the Berry’s Creek site. The Company has joined the group of PRPs and entered into an Administrative Settlement Agreement (“Agreement”) and Order on Consent with the USEPA agreeing to jointly conduct or fund an appropriate remedial investigation and feasibility study of the Berry’s Creek site with the other PRPs in the Agreement. The PRPs have engaged consultants to perform the work specified in the Agreement and develop a method to allocate related costs among the PRPs.

June 2016,

the PRPs received a request from USEPA to amend the RI/FS Work Plan to accommodate a phased, iterative approach to the Berry’s Creek remediation. USEPA requested an initial interim remedy that focuses on a portion of the site, namely, sediments in Upper and Middle Berry’s Creek and the marsh in Upper Peach Island Creek. Any subsequent remedial action will occur after the implementation and performance monitoring of this interim remedy and the extent of future action is expected to be at least partially determined by the outcome of this initial phase. In

April 2017,

USEPA approved the requested addendum to the RI/FS Work Plan, which included the description of the phased and adaptive management approach to the Berry’s Creek remedy.

The scope of remedial activities in the initial interim remedy is currently being developed and based upon preliminary cost estimates, the Company’s reserve was

$9,829

as of

September 30, 2017.

The estimated costs for the initial interim remedy

may

be further developed over the next several months and the Company’s accrual

may

change based upon the final remedy selected and revisions to cost estimates. At this time it is

not

known when the costs for the complete remediation plan will be estimable, and as such,

accrual beyond the initial interim remedy has been recorded. The Company’s share has been preliminarily estimated by the PRP group at

2.4%.

While the Company will defend its position that its share should be reduced from the current level, its share could be increased or decreased depending on the outcome of the final allocation process that will take place in future periods.

While any resolution of this matter is

not

expected to materially impact the Company’s operations or financial position, it could be material to the financial statements in the period recorded.

July 2014,

the Company received a notice from the U.S. Department of the Interior, U.S. Fish & Wildlife Service, regarding the Company’s potential liability for natural resource damages at the Berry’s Creek

site and inviting the Company to participate in a cooperative assessment of natural resource damages. Most members of the Berry

’s Creek PRP group received such notice letters, and the PRP Group coordinated a joint response, which was to decline participation in a cooperative assessment at this time, given existing investigation work at the site. The cost of any future assessment and the ultimate scope of natural resource damage liability are

not

yet known.

Maybrook Site

1986.

The PRPs implemented soil remediation which was completed in

2012

pending approval by the USEPA. The PRPs will continue implementing the ground water remediation at the site. In

May 2017,

the Company made a payment to USEPA in the amount of

$363

for ongoing oversight costs. As of

September 30, 2017,

the Company’s reserve was

$329,

to cover long-term ground water monitoring and related costs.

Harriman Site

1997

(the

“1997

ROD”) and incorporated into a federal court Consent Decree in

1998

(the “Consent Decree”). In

December 2013,

the Company, Pfizer and the NYSDEC entered into a federal court stipulation, which the court subsequently endorsed as a court order, resolving certain disputes with the NYSDEC about the scope of the obligations under the Consent Decree and the

1997

ROD, and requiring the Company and Pfizer to carry out an environmental investigation and study of certain areas of the Harriman Site.

Site clean-up work under the

1997

ROD, the Consent Decree and the

2013

stipulation is ongoing and is being jointly performed by Pfizer and the Company, with NYSDEC oversight. Since

2014,

Pfizer and the Company have performed supplemental remedial investigation measures requested by the NYSDEC, and the findings have been submitted to NYSDEC in various reports, including a study evaluating the feasibility of certain remedial alternatives in

August 2016.

By letter dated

January 5, 2017,

NYSDEC disapproved such feasibility study report and requested certain revisions to the report. The Company and Pfizer engaged in further discussions with NYSDEC and have agreed to submit a revised version of the

August 2016

feasibility study to address certain of NYSDEC’s requests. In

September 2017,

the NYSDEC requested that Pfizer, the Company and the current owner of the Harriman Site, ELT Harriman LLC (“ELT”), conduct an investigation of additional constituents

not

addressed under the

1997

ROD based on the detection of those constituents at the Harriman Site and other properties in the area. The parties have requested more information from the State of New York to evaluate the request.

As it is too soon to determine whether the NYSDEC’s requests or the reports and remedial plans, when finalized, will result in any significant changes to the Company’s responsibilities,

change to the reserve has been made. ELT is conducting other investigation and remediation activities under a separate NYSDEC directive.

final remedy for the site has been determined, which will follow further discussions with the NYSDEC. The Company estimates the range for its share of the liability at the site to be between

$2,000

and

$7,000.

As of

September 30, 2017,

the Company’s reserve was

$3,465.

At this time, the Company is unable to provide an estimate of the ultimate investigative and remedial costs to the Company for any final remedy selected by the NYSDEC.

The Company intends to enforce all of its contractual rights to recover costs and for indemnification under a

2007

settlement agreement, and has filed such claims in an arbitration proceeding against ELT and the immediately preceding owner, Vertellus Specialties Holdings (“Vertellus”). ELT has filed counterclaims, and has threatened to file additional counterclaims, for contractual indemnification and for breach of the settlement agreement against the Company. Currently, the arbitration proceeding is stayed indefinitely. In

May 2016,

some but

not

all of the Vertellus entities who are parties to the Company’s

2007

settlement agreement filed for restructuring under Chapter

of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. The Company has filed several claims as creditors in the bankruptcy proceeding and will continue to monitor the bankruptcy proceeding.

Scientific Chemical Processing (“SCP”) Superfund Site

A subsidiary of Cambrex was named a PRP of the SCP Superfund site, located in Carlstadt, New Jersey, along with approximately

130

other PRPs. The site is a former waste processing facility that accepted various waste for recovery and disposal including processing wastewater from this subsidiary. The PRPs are in the process of implementing a final remedy at the site. The SCP Superfund site has also been identified as a PRP in the Berry’s Creek Superfund site (see previous discussion). While the Company continues to dispute the methodology used by the PRP group to arrive at its interim allocation for cash contributions, the Company has paid the funding requests. A final allocation of SCP Site costs (excluding Berry’s Creek costs) is expected to be finalized in early

2018.

As of

September 30, 2017,

the Company’s reserve was

$762,

of which approximately

$488

is expected to be covered by insurance.

Newark Bay Complex

not

involved in the USEPA action, it continues to monitor developments related to the site due to its past involvement in a previously settled state action relating to the Newark Bay Complex. The USEPA has finalized its decision on a cleanup plan for

8.3

miles of the lower Passaic River, and has estimated the cost of this plan at

$1.38

billion. Due to the uncertainty of the future scope and timing of any possible claims against the Company,

liability has been recorded.

The Company is involved in other related and unrelated environmental matters where the range of liability is

not

reasonably estimable at this time and it is

not

foreseeable when information will become available to provide a basis for adjusting or recording a reserve, should a reserve ultimately be required.

Litigation and Other Matters

Lorazepam and Clorazepate

1998,

the Company and a subsidiary were named as defendants along with Mylan Laboratories, Inc. (“Mylan”) and Gyma Laboratories, Inc. (“Gyma”) in a proceeding instituted by the Federal Trade Commission in the United States District Court for the District of Columbia (the “District Court”). Suits were also

commenced by several State Attorneys General and class action complaints by private plaintiffs in various state courts. The suits alleged violations of the Federal Trade Commission Act arising from exclusive license agreements between the Company and Mylan covering

two

APIs (Lorazepam and Clorazepate).

All cases have been resolved except for

one

brought by

four

health care insurers. In the remaining case, the District Court entered judgment after trial in

2008

against Mylan, Gyma and Cambrex. The judgment was appealed to the United States Court of Appeals for the District of Columbia Circuit (the “D.C. Circuit”) in

2011,

resulting in a remand to the District Court. On remand, the District Court dismissed certain self-funded customer plaintiffs due to their failure to satisfy the requirements of federal jurisdiction. Subsequently, the District Court entered an order remitting certain damages. Without fees, costs, or post-judgment interest, the current judgment against Mylan, Gyma, and Cambrex is

$67,260.

Mylan, Gyma, and Cambrex have once again appealed to the D.C. Circuit and the appeal is currently pending.

2003,

Cambrex paid

$12,415

to Mylan in exchange for a release and full indemnity against future costs or liabilities in related litigation brought by the purchasers of Lorazepam and Clorazepate, as well as potential future claims related to the ongoing matter. In the event of a final settlement or final judgment, Cambrex expects any payment required by the Company to be made by Mylan under the indemnity described above.

XML 29 R19.htm IDEA: XBRL DOCUMENT

Note 12 - Discontinued Operations

9 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

(

)

Discontinued Operations

	Three months ended September 30,						Nine months ended September 30,
	2017			2016			2017			2016

Pre-tax income/(loss) from discontinued operations	$	126		$	(6,928	)	$	(1,946	)	$	(7,819	)
Income tax (expense)/benefit		(106	)		2,425			622			2,737
Income/(loss) from discontinued operations, net of tax	$	20		$	(4,503	)	$	(1,324	)	$	(5,082	)

As of

September 30, 2017

and

December 31, 2016,

liabilities recorded on the Company

’s balance sheet related to discontinued operations were

$17,434

and

$16,703,

respectively. At this time, the Company cannot reasonably estimate the period of time during which the involvement is expected to continue. Net cash used in discontinued operations for the

nine

months ended

September 30, 2017

and

2016

were

$1,185

and

$312,

respectively. Refer to Note

to the Company’s consolidated financial statements for further disclosures on the Company’s environmental contingencies.

XML 30 R20.htm IDEA: XBRL DOCUMENT

Note 3 - Net Inventories (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Inventory, Current [Table Text Block]

	September 30,		December 31,
	2017		2016

Finished goods	$	49,771	$	29,117
Work in process		64,168		54,463
Raw materials		44,355		33,841
Supplies		6,619		5,763
Total	$	164,913	$	123,184

XML 31 R21.htm IDEA: XBRL DOCUMENT

Note 4 - Goodwill and Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Goodwill [Table Text Block]

Balance as of December 31, 2016	$	40,323
Translation effect		2,877
Balance as of September 30, 2017	$	43,200

Schedule of Finite-Lived Intangible Assets [Table Text Block]

				As of September 30, 2017
	Amortization Period (in years)			Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount

Internal-use software	3	-	7	$	6,971	$	(1,535	)	$	5,436
Technology-based intangibles		20			3,589		(1,346	)		2,243
Customer-related intangibles	10	-	15		7,597		(1,047	)		6,550
				$	18,157	$	(3,928	)	$	14,229

				As of December 31, 2016
	Amortization Period (in years)			Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount

Internal-use software	3	-	7	$	6,444	$	(829	)	$	5,615
Technology-based intangibles		20			3,204		(1,082	)		2,122
Customer-related intangibles	10	-	15		7,522		(459	)		7,063
				$	17,170	$	(2,370	)	$	14,800

XML 32 R22.htm IDEA: XBRL DOCUMENT

Note 7 - Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

Fair Value - Level 2		September 30, 2017				December 31, 2016
Foreign currency forwards, assets		$	193			$	125

XML 33 R23.htm IDEA: XBRL DOCUMENT

Note 8 - Accumulated Other Comprehensive Income/(Loss) (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

	Foreign Currency Translation Adjustments			Pension Plans			Total
Balance as of June 30, 2017	$	(21,543	)	$	(30,743	)	$	(52,286	)
Other comprehensive income before reclassifications		7,006			-			7,006
Amounts reclassified from accumulated other comprehensive loss		-			250			250
Net current-period other comprehensive income		7,006			250			7,256
Balance as of September 30, 2017	$	(14,537	)	$	(30,493	)	$	(45,030	)

	Foreign Currency Translation Adjustments			Pension Plans			Total
Balance as of June 30, 2016	$	(25,168	)	$	(29,165	)	$	(54,333	)
Other comprehensive income before reclassifications		235			-			235
Amounts reclassified from accumulated other comprehensive loss		-			202			202
Net current-period other comprehensive income		235			202			437
Balance as of September 30, 2016	$	(24,933	)	$	(28,963	)	$	(53,896	)

	Foreign Currency Translation Adjustments			Pension Plans			Total
Balance as of December 31, 2016	$	(34,290	)	$	(31,230	)	$	(65,520	)
Other comprehensive income before reclassifications		19,753			-			19,753
Amounts reclassified from accumulated other comprehensive loss		-			737			737
Net current-period other comprehensive income		19,753			737			20,490
Balance as of September 30, 2017	$	(14,537	)	$	(30,493	)	$	(45,030	)

	Foreign Currency Translation Adjustments			Pension Plans			Total
Balance as of December 31, 2015	$	(25,880	)	$	(29,569	)	$	(55,449	)
Other comprehensive income before reclassifications		947			-			947
Amounts reclassified from accumulated other comprehensive loss		-			606			606
Net current-period other comprehensive income		947			606			1,553
Balance as of September 30, 2016	$	(24,933	)	$	(28,963	)	$	(53,896	)

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]

Details about AOCI Components	Three months ended September 30, 2017			Nine months ended September 30, 2017

Amortization of defined benefit pension items:
Actuarial losses	$	(355	)	$	(1,048	)
Prior service costs		(13	)		(39	)
Total before tax		(368	)		(1,087	)
Tax benefit		118			350
Net of tax	$	(250	)	$	(737	)

Total reclassification for the period	$	(250	)	$	(737	)

Details about AOCI Components	Three months ended September 30, 2016			Nine months ended September 30, 2016

Amortization of defined benefit pension items:
Actuarial losses	$	(288	)	$	(867	)
Prior service costs		(14	)		(39	)
Total before tax		(302	)		(906	)
Tax benefit		100			300
Net of tax	$	(202	)	$	(606	)

Total reclassification for the period	$	(202	)	$	(606	)

XML 34 R24.htm IDEA: XBRL DOCUMENT

Note 9 - Stock Based Compensation (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Share-based Compensation, Stock Options, Activity [Table Text Block]

Options	Number of Shares			Weighted Average Exercise Price

Outstanding at December 31, 2016		1,519,338		$	25.22
Granted		39,037			54.15
Exercised		(61,249	)		11.83
Outstanding at March 31, 2017		1,497,126			26.52
Granted		19,598			58.98
Exercised		(162,431	)		13.84
Outstanding at June 30, 2017		1,354,293			28.51
Exercised		(55,950	)		8.48
Outstanding at September 30, 2017		1,298,343			29.37
Exercisable at September 30, 2017		449,959		$	21.09

Schedule of Nonvested Share Activity [Table Text Block]

	Unvested Stock Options					Unvested Restricted Stock					Unvested Performance Shares
	Number of Shares			Weighted- Average Grant-Date Fair Value		Number of Shares			Weighted- Average Grant-Date Fair Value		Number of Shares			Weighted- Average Grant-Date Fair Value

Unvested at December 31, 2016		817,540		$	12.50		260		$	41.05		316,750		$	30.08
Granted		39,037			21.02		-			-		-			-
Vested during period		(14,975	)		8.16		-			-		-			-
Unvested at March 31, 2017		841,602			12.97		260			41.05		316,750			30.08
Granted		19,598			18.37		9,496			58.98		5,750			41.36
Vested during period		(12,816	)		8.50		(260	)		41.05		-			-
Unvested at June 30, 2017		848,384			13.17		9,496			58.98		322,500			30.28
Vested during period		-			-		-			-		(150,000	)		17.81
Unvested at September 30, 2017		848,384		$	13.17		9,496		$	58.98		172,500		$	41.12

XML 35 R25.htm IDEA: XBRL DOCUMENT

Note 10 - Retirement Plans (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Schedule of Net Benefit Costs [Table Text Block]

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016

Components of net periodic benefit cost
Interest cost	$	553		$	597		$	1,661		$	1,792
Expected return on plan assets		(677	)		(662	)		(2,031	)		(1,986	)
Recognized actuarial loss		199			194			599			582
Net periodic benefit cost	$	75		$	129		$	229		$	388

	Three months ended						Nine months ended
	September 30,						September 30,
	2017			2016			2017			2016

Components of net periodic benefit cost
Service cost	$	247		$	186		$	700		$	561
Interest cost		192			186			545			560
Recognized actuarial loss		94			49			268			147
Amortization of prior service benefit		(1	)		(1	)		(3	)		(3	)
Net periodic benefit cost	$	532		$	420		$	1,510		$	1,265

XML 36 R26.htm IDEA: XBRL DOCUMENT

Note 12 - Discontinued Operations (Tables)

9 Months Ended

Sep. 30, 2017

Notes Tables

Disposal Groups, Including Discontinued Operations [Table Text Block]

	Three months ended September 30,						Nine months ended September 30,
	2017			2016			2017			2016

Pre-tax income/(loss) from discontinued operations	$	126		$	(6,928	)	$	(1,946	)	$	(7,819	)
Income tax (expense)/benefit		(106	)		2,425			622			2,737
Income/(loss) from discontinued operations, net of tax	$	20		$	(4,503	)	$	(1,324	)	$	(5,082	)

- Definition

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=65878427&loc=SL51721533-107759

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721665-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64827811&loc=d3e1474-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64827811&loc=d3e1361-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721683-107760

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=84176398&loc=SL51724579-110230

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721675-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721663-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84176398&loc=d3e2941-110230

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721673-107760

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721659-107760

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5A
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721671-107760

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5D
-URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721677-107760

+ Details

XML 37 R27.htm IDEA: XBRL DOCUMENT

Note 2 - Impact of Recently Issued Accounting Pronouncements (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Unrecognized Excess Tax Benefits					$ 0
Income Tax Expense (Benefit)	$ 7,498	$ 5,443	$ 22,484	$ 21,784
Effective Income Tax Rate Reconciliation, Percent	30.30%	28.40%	26.10%	30.60%
Accounting Standards Update 2016-09 [Member]
Income Tax Expense (Benefit)			$ (5,114)
Effective Income Tax Rate Reconciliation, Percent			(6.00%)
Reclassification from Financing Activities to Operating Activities [Member] \| Six Months Ended June 30, 2016 [Member]
Prior Period Reclassification Adjustment			$ 2,958

XML 38 R28.htm IDEA: XBRL DOCUMENT

Note 3 - Net Inventories - Schedule of Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Finished goods	$ 49,771	$ 29,117
Work in process	64,168	54,463
Raw materials	44,355	33,841
Supplies	6,619	5,763
Total	$ 164,913	$ 123,184

XML 39 R29.htm IDEA: XBRL DOCUMENT

Note 4 - Goodwill and Intangible Assets (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Amortization of Intangible Assets	$ 477	$ 227	$ 1,375	$ 614
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	1,881		1,881
Finite-Lived Intangible Assets, Amortization Expense, Year Two	2,019		2,019
Finite-Lived Intangible Assets, Amortization Expense, Year Four	2,003		2,003
Finite-Lived Intangible Assets, Amortization Expense, Year Three	2,019		2,019
Finite-Lived Intangible Assets, Amortization Expense, Year Five	$ 2,003		$ 2,003

XML 40 R30.htm IDEA: XBRL DOCUMENT

Note 4 - Goodwill and Intangible Assets - Change in Carrying Amount of Goodwill (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2017 USD ($)
Goodwill Balance	$ 40,323
Translation effect	2,877
Goodwill Balance	$ 43,200

XML 41 R31.htm IDEA: XBRL DOCUMENT

Note 4 - Goodwill and Intangible Assets - Summary of Acquired Amortizable Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Gross Carrying Amount	$ 18,157	$ 17,170
Accumulated Amortization	(3,928)	(2,370)
Net Carrying Amount	14,229	14,800
Computer Software, Intangible Asset [Member]
Gross Carrying Amount	6,971	6,444
Accumulated Amortization	(1,535)	(829)
Net Carrying Amount	$ 5,436	$ 5,615
Computer Software, Intangible Asset [Member] \| Minimum [Member]
Amortization Period (Year)	3 years	3 years
Computer Software, Intangible Asset [Member] \| Maximum [Member]
Amortization Period (Year)	7 years	7 years
Technology-Based Intangibles [Member]
Amortization Period (Year)	20 years	20 years
Gross Carrying Amount	$ 3,589	$ 3,204
Accumulated Amortization	(1,346)	(1,082)
Net Carrying Amount	2,243	2,122
Customer Contracts [Member]
Gross Carrying Amount	7,597	7,522
Accumulated Amortization	(1,047)	(459)
Net Carrying Amount	$ 6,550	$ 7,063
Customer Contracts [Member] \| Minimum [Member]
Amortization Period (Year)	10 years	10 years
Customer Contracts [Member] \| Maximum [Member]
Amortization Period (Year)	15 years	15 years

XML 42 R32.htm IDEA: XBRL DOCUMENT

Note 5 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Tax Expense (Benefit)	$ 7,498	$ 5,443	$ 22,484	$ 21,784
Effective Income Tax Rate Reconciliation, Percent	30.30%	28.40%	26.10%	30.60%
Effective Income Tax Rate, Continuing Operations Before ASU Adoption			32.10%
Accounting Standards Update 2016-09 [Member]
Income Tax Expense (Benefit)			$ (5,114)
Effective Income Tax Rate Reconciliation, Percent			(6.00%)

XML 43 R33.htm IDEA: XBRL DOCUMENT

Note 6 - Derivatives (Details Textual) - Foreign Exchange Contract [Member] - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Derivative, Notional Amount	$ 37,626	$ 20,896
Prepaid Expenses and Other Current Assets [Member]
Derivative Asset, Fair Value, Gross Asset	$ 193	$ 125

XML 44 R34.htm IDEA: XBRL DOCUMENT

Note 7 - Fair Value Measurements - Assets and Liabilities Carried at Fair Value Measured on a Recurring Basi (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member]
Foreign currency forwards, assets (liabilities)	$ 193	$ 125

XML 45 R35.htm IDEA: XBRL DOCUMENT

Note 8 - Accumulated Other Comprehensive Income/(Loss) - Changes in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Beginning balance			$ 405,427
Ending balance	$ 497,877		497,877
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Beginning balance	(21,543)	$ (25,168)	(34,290)	$ (25,880)
Other comprehensive income before reclassifications	7,006	235	19,753	947
Amounts reclassified from accumulated other comprehensive loss
Net current-period other comprehensive income	7,006	235	19,753	947
Ending balance	(14,537)	(24,933)	(14,537)	(24,933)
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Beginning balance	(30,743)	(29,165)	(31,230)	(29,569)
Other comprehensive income before reclassifications
Amounts reclassified from accumulated other comprehensive loss	250	202	737	606
Net current-period other comprehensive income	250	202	737	606
Ending balance	(30,493)	(28,963)	(30,493)	(28,963)
AOCI Attributable to Parent [Member]
Beginning balance	(52,286)	(54,333)	(65,520)	(55,449)
Other comprehensive income before reclassifications	7,006	235	19,753	947
Amounts reclassified from accumulated other comprehensive loss	250	202	737	606
Net current-period other comprehensive income	7,256	437	20,490	1,553
Ending balance	$ (45,030)	$ (53,896)	$ (45,030)	$ (53,896)

XML 46 R36.htm IDEA: XBRL DOCUMENT

Note 8 - Accumulated Other Comprehensive Income/(Loss) - Reclassifications Out of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Selling, general and administrative expenses	$ 17,551	$ 14,950	$ 51,785	$ 42,602
Total before tax	24,774	19,164	85,999	71,160
Tax benefit	(7,498)	(5,443)	(22,484)	(21,784)
Amounts reclassified from accumulated other comprehensive loss	17,296	9,218	62,191	44,294
Reclassification out of Accumulated Other Comprehensive Income [Member]
Amounts reclassified from accumulated other comprehensive loss	(250)	(202)	(737)	(606)
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member]
Cost of goods sold, selling, general, and administrative expenses	(355)	(288)	(1,048)	(867)
Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member]
Selling, general and administrative expenses	(13)	(14)	(39)	(39)
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member]
Total before tax	(368)	(302)	(1,087)	(906)
Tax benefit	118	100	350	300
Amounts reclassified from accumulated other comprehensive loss	$ (250)	$ (202)	$ (737)	$ (606)

XML 47 R37.htm IDEA: XBRL DOCUMENT

Note 9 - Stock Based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 20.14	$ 13.82
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	$ 7,224		$ 7,224
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			1 year 328 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value	2,669	$ 173	$ 12,011	$ 8,195
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	33,350		33,350
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	15,256		15,256
Employee Stock Option [Member] \| Selling, General and Administrative Expenses [Member]
Stock or Unit Option Plan Expense	1,187	1,012	3,313	2,836
Restricted Stock [Member]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	93		$ 93
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			36 days
Restricted Stock [Member] \| Selling, General and Administrative Expenses [Member]
Restricted Stock or Unit Expense	280	240	$ 474	406
Performance Shares [Member]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	3,143		$ 3,143
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			1 year 109 days
Performance Shares [Member] \| Selling, General and Administrative Expenses [Member]
Performance Share Expense	$ 821	$ 637	$ 2,534	$ 1,947

XML 48 R38.htm IDEA: XBRL DOCUMENT

Note 9 - Stock Based Compensation - Summary of Stock Option Activity (Details) - Employee Stock Option [Member] - $ / shares	3 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017
Outstanding, beginning balance (in shares)	1,354,293	1,497,126	1,519,338
Outstanding, beginning balance, weighted average exercise price (in dollars per share)	$ 28.51	$ 26.52	$ 25.22
Granted (in shares)		19,598	39,037
Granted, weighted average exercise price (in dollars per share)		$ 58.98	$ 54.15
Exercised (in shares)	(55,950)	(162,431)	(61,249)
Exercised, weighted average exercise price (in dollars per share)	$ 8.48	$ 13.84	$ 11.83
Exercised, weighted average exercise price (in dollars per share)	$ 8.48	$ 13.84	$ 11.83
Outstanding, ending balance (in shares)	1,298,343	1,354,293	1,497,126
Outstanding, ending balance, weighted average exercise price (in dollars per share)	$ 29.37	$ 28.51	$ 26.52
Exercised (in shares)	449,959
Exercised, weighted average exercise price (in dollars per share)	$ 21.09

XML 49 R39.htm IDEA: XBRL DOCUMENT

Note 9 - Stock Based Compensation - Summary of Nonvested Stock Options, Restricted Stock and Performance Shares (Details) - $ / shares	3 Months Ended
	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017
Employee Stock Option [Member]
Nonvested Stock Options, beginning balance (in shares)	848,384	841,602	817,540
Nonvested Stock Options, beginning balance, weighted average grant date fair value (in dollars per share)	$ 13.17	$ 12.97	$ 12.50
Granted, nonvested stock options (in shares)		19,598	39,037
Granted, weighted average grant date fair value (in dollars per share)		$ 18.37	$ 21.02
Vested during period, nonvested stock options (in shares)		(12,816)	(14,975)
Vested during period, weighted average grant date fair value (in dollars per share)		$ 8.50	$ 8.16
Nonvested Stock Options, ending balance (in shares)	848,384	848,384	841,602
Nonvested Stock Options, ending balance, weighted average grant date fair value (in dollars per share)	$ 13.17	$ 13.17	$ 12.97
Restricted Stock [Member]
Nonvested equity awards other than options, beginning balance (in shares)	9,496	260	260
Nonvested equity awards other than options, beginning balance, weighted average grant date fair value (in dollars per share)	$ 58.98	$ 41.05	$ 41.05
Granted, equity awards other than options (in shares)		9,496	0
Granted, equity awards other than options, weighted average grant date fair value (in dollars per share)		$ 58.98	$ 0
Vested during period, equity awards other than options (in shares)		(260)	0
Vested during period, equity awards other than options, weighted average grant date fair value (in dollars per share)		$ 41.05	$ 0
Nonvested equity awards other than options, ending balance (in shares)	9,496	9,496	260
Nonvested equity awards other than options, ending balance, weighted average grant date fair value (in dollars per share)	$ 58.98	$ 58.98	$ 41.05
Performance Shares [Member]
Nonvested equity awards other than options, beginning balance (in shares)	322,500	316,750	316,750
Nonvested equity awards other than options, beginning balance, weighted average grant date fair value (in dollars per share)	$ 30.28	$ 30.08	$ 30.08
Granted, equity awards other than options (in shares)		5,750	0
Granted, equity awards other than options, weighted average grant date fair value (in dollars per share)		$ 41.36	$ 0
Vested during period, equity awards other than options (in shares)	(150,000)	0	0
Vested during period, equity awards other than options, weighted average grant date fair value (in dollars per share)	$ 17.81	$ 0	$ 0
Nonvested equity awards other than options, ending balance (in shares)	172,500	322,500	316,750
Nonvested equity awards other than options, ending balance, weighted average grant date fair value (in dollars per share)	$ 41.12	$ 30.28	$ 30.08

XML 50 R40.htm IDEA: XBRL DOCUMENT

Note 10 - Retirement Plans (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Supplemental Employee Retirement Plan [Member]
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)	$ 77	$ 65	$ 231	$ 194

XML 51 R41.htm IDEA: XBRL DOCUMENT

Note 10 - Retirement Plans - Components of Net Periodic Benefit Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Domestic Plan [Member]
Components of net periodic benefit cost
Interest cost	$ 553	$ 597	$ 1,661	$ 1,792
Expected return on plan assets	(677)	(662)	(2,031)	(1,986)
Recognized actuarial loss	199	194	599	582
Net periodic benefit cost	75	129	229	388
Foreign Plan [Member]
Components of net periodic benefit cost
Interest cost	192	186	545	560
Recognized actuarial loss	94	49	268	147
Net periodic benefit cost	532	420	1,510	1,265
Service cost	247	186	700	561
Amortization of prior service benefit	$ (1)	$ (1)	$ (3)	$ (3)

XML 52 R42.htm IDEA: XBRL DOCUMENT

Note 11 - Contingencies (Details Textual) $ in Thousands	1 Months Ended	9 Months Ended	12 Months Ended
Note 11 - Contingencies (Details Textual) $ in Thousands	May 30, 2017 USD ($)	Sep. 30, 2017 USD ($) mi²	Dec. 31, 2008	Dec. 31, 2003 USD ($)	Dec. 31, 2016 USD ($)
Accrual for Environmental Loss Contingencies		$ 17,434			$ 16,703
Accrual for Environmental Loss Contingencies, Period Increase (Decrease)		2,419
Accrual for Environmental Loss Contingencies, Payments		1,688
Lorazepam and Clorazepate [Member]
Loss Contingency, Number of Plaintiffs			4
Judgment Amount Against Parties Payable Jointly and Severally		67,260
Lorazepam and Clorazepate [Member] \| Indemnification Agreement [Member]
Payment in Exchange for Release and Full Indemnity Against Future Cost or Liabilities				$ 12,415
Bayonne [Member]
Accrual for Environmental Loss Contingencies		450
Clifton and Carlstadt [Member]
Accrual for Environmental Loss Contingencies		1,889
Berrys Creek Site [Member]
Accrual for Environmental Loss Contingencies		$ 9,829
Number of Subsidiaries Notice Received		2
Environmental Exit Costs, Reasonably Possible Losses, Estimated Share		2.40%
Maybrook Site [Member]
Accrual for Environmental Loss Contingencies		$ 329
Accrual for Environmental Loss Contingencies, Payments	$ 363
Harriman Site [Member]
Accrual for Environmental Loss Contingencies		3,465
Harriman Site [Member] \| Minimum [Member]
Site Contingency Loss Exposure, Estimated Range		2,000
Harriman Site [Member] \| Maximum [Member]
Site Contingency Loss Exposure, Estimated Range		7,000
Scientific Chemical Processing SCP Superfund Site [Member]
Accrual for Environmental Loss Contingencies		$ 762
Number of Other Sites Named PRP of SCP Superfund Site		130
Site Contingency, Recovery from Third Party of Environmental Remediation Cost		$ 488
Newark Bay Complex Litigation [Member]
Accrual for Environmental Loss Contingencies		$ 0
Site Contingency Clean Up Plan, Miles of Clean Up \| mi²		8.3
Amount of Estimated Cost to Clean Up Site that the Company is Not Exposed		$ 1,380,000
Other Noncurrent Liabilities [Member]
Accrual for Environmental Loss Contingencies		$ 16,881			$ 15,441

XML 53 R43.htm IDEA: XBRL DOCUMENT

Note 12 - Discontinued Operations (Details Textual) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Discontinued Operation, Amounts of Material Contingent Liabilities Remaining	$ 17,434		$ 16,703
Cash Provided by (Used in) Operating Activities, Discontinued Operations	$ (1,185)	$ (312)

- Definition

Amounts of material contingent liabilities, for example, but not limited to, product or environmental liabilities or litigation, that remain with the entity despite the disposal of the disposal group that is classified as a component of the entity.

+ References + Details

XML 54 R44.htm IDEA: XBRL DOCUMENT

Note 12 - Discontinued Operations - Reconciliation of the Pre-tax Loss on Discontinued Operations to the Net Loss on Discontinued Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Pre-tax income/(loss) from discontinued operations	$ 126	$ (6,928)	$ (1,946)	$ (7,819)
Income tax (expense)/benefit	(106)	2,425	622	2,737
Income/(loss) from discontinued operations, net of tax	$ 20	$ (4,503)	$ (1,324)	$ (5,082)

- Definition

Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.

+ References + Details

- Definition

Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.

+ References + Details

- Definition

Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.

+ References + Details

EXCEL 55 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end